Living weapons: Biological warfare and international security

Living Weapons: Biological Warfare and International Security

Volumn , Issue , 2009, Pages 1-256

  Koblentz, Gregory D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85036569388     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Book

References (635)

1. Secretary of State Colin Powell, “Remarks to the United Nations Security Council,” New York City, February 5, 2003, http://www.state.gov/secretary/former/powell/remarks/2003/17300.htm.
2. The Commission on the Intelligence Capabilities of the United States Regarding Weapons of Mass Destruction, Report to the President (Washington, DC: GPO, 2005), 48.
3. Gregory Koblentz, “Pathogens as Weapons: The International Security Implications of Biological Warfare,” International Security 28, no. 3 (2003/4): 84-122.
4. Thomas Schelling, foreword to Pearl Harbor: Warning and Decision by Roberta Wohlstetter (Stanford: Stanford University Press, 1962), vii.
5. Malcolm Dando, The New Biological Weapons: Threat, Proliferation, and Control (Boulder, CO: Lynne Reinner, 2001).
6. Erhard Geissler and John Ellis van Courtland Moon, eds., Biological and Toxin Weapons: Research, Development and Use from the Middle Ages to 1945 (Oxford: Oxford University Press, 1999); Mark
7. Wheelis, Lajos Rozsa, and Malcolm Dando, eds., Deadly Cultures: Biological Weapons since 1945 (Cambridge: Harvard University Press, 2006)
8. Jeanne Guillemin, Biological Weapons: From the Invention of State-Sponsored Programs to Contemporary Bioterrorism (New York: Columbia University Press, 2005).
9. William H. McNeill, Plagues and People (New York: Anchor Books, 1998), 288-89
10. Jared Diamond, Guns, Germs and Steel: The Fates of Human Societies (New York: WW Norton, 1999), 195-214.
11. Adrienne Mayor, Greek Fire, Poison Arrow, and Scorpion Bombs: Biological and Chemical Warfare in the Ancient World (Woodstock, NY: Overlook, 2003), 99-118.
12. Mark Wheelis, “Biological Warfare before 1914,” in Biological and Toxin Weapons, ed. Geissler and Moon, 8-34.
13. Mark Wheelis, “Biological Sabotage in World War I,” in Biological and Toxin Weapons, ed. Geissler and Moon, 35-62.
14. Erhard Geissler, “Biological Warfare Activities in Germany, 1923-1945,” in Biological and Toxin Weapons, ed. Geissler and Moon, 91-126.
15. Sheldon Harris, “The Japanese Biological Warfare Programme: An Overview,” in Biological and Toxin Weapons, ed. Geissler and Moon, 127-52
16. Sheldon Harris, Factories of Death: Japanese Biological Warfare 1932-1945 and the American Cover Up (London: Routledge, 1994).
17. Marléne Burger and Chandré Gould, Secrets and Lies: Wouter Basson and South Africa's Chemical and Biological Warfare Programme (Cape Town, S.A.: Zebra Press, 2002), 15-16, 221-22
18. Chandré Gould, “South Africa’s Chemical and Biological Warfare Programme, 1981-1995” (PhD diss., Rhodes University, Grahamstown, S.A., 2005), 35-42.
19. Chandré Gould and Peter Folb, Project Coast: Apartheid’s Chemical and Biological Warfare Programme (Geneva: United Nations Publications, 2002), 86-99, 103-4, 115-16, 159-67.
20. John Ellis van Courtland Moon, “U.S. Biological Warfare Planning and Preparedness: The Dilemmas of Policy,” in Biological and Toxin Weapons, ed. Geissler and Moon, 238-39
21. Robert Harris and Jeremy Paxman, Higher Form of Killing: The Secret History of Chemical and Biological Warfare (New York: Random House, 2002), 78.
22. Ken Alibek, Biohazard: The Chilling True Story of the Largest Covert Biological Weapons Program in the World-Told from the Inside by the Man Who Ran It, with Stephen Handelman (New York: Random House, 1999), 299-301.
23. Department of the Army, Army Activities in the U.S. Biological Warfare Programs (Washington, DC: Department of the Army, February 24, 1977), 2:D-2.
24. Kenneth Alibek before the Joint Economic Committee, Terrorist and Intelligence Operations: Potential Impact on the U.S. Economy, 105th Cong., 2nd ses., May 20, 1998, http://www.house.gov/jec/hearings/intell/alibek.htm.
25. Wendy Orent, “After Anthrax,” American Prospect 11, no. 12 (2000)
26. Richard O. Spertzel, Robert W. Wannemacher, and Carol D. Linden, Global Proliferation: Dynamics, Acquisition Strategies, and Responses, vol. 4, Biological Weapons Proliferation (Washington, DC: Defense Nuclear Agency, 1994), 21.
27. William C. Patrick III, “Biological Warfare: An Overview,” Director’s Series on Proliferation 4 (Livermore, CA: Lawrence Livermore National Laboratory, May 1994), 5.
28. Leroy Fothergill, “The Biological Warfare Threat,” Nonmilitary Defense: Chemical and Biological Defenses in Perspective, Advances in Chemistry Series 26 (Washington, DC: American Chemical Society, July 1960), 26.
29. Thomas V. Inglesby et al., “Anthrax as a Biological Weapon: Medical and Public Health Management,” Journal of the American Medical Association 281, no. 18 (1999): 1738.
30. Stockholm International Peace Research Institute (SIPRI), Problem of Chemical and Biological Warfare, vol. 2, CB Weapons Today (New York: Humanities Press, 1973), 132-38
31. Graham S. Pearson, “Prospects for Chemical and Biological Arms Control: The Web of Deterrence,” Washington Quarterly 16, no. 2 (1993): 147-48.
32. John Ellis Van Courtland Moon, “The U.S. Biological Weapons Program,” in Deadly Cultures, ed. Wheelis, Rozsa, and Dando, 9-46
33. Ed Regis, The Biology of Doom: The History of America's Secret Germ Warfare Project (New York: Henry Holt, 1999).
34. A. Alibek, Biohazard, 96-97, 132.
35. Brian Balmer, Britain and Biological Warfare: Expert Advice and Science Policy, 1930-1965 (London: Palgrave Macmillan, 2001)
36. Olivier Lepick, “The French Biological Weapons Program,” in Deadly Cultures, ed. Wheelis, Rozsa, and Dando, 108-31.
37. Department of State, Adherence to and Compliance with Arms Control, Nonproliferation, and Disarmament Agreements and Commitments (Washington, DC: Department of State, 2005), 17-18, 20-21, 26-27, 31.
38. Avner Cohen, “Israel and Chemical/Biological Weapons: History, Deterrence, and Arms Control,” Nonproliferation Review 8, no. 3 (2001): 27-53.
39. United Nations Monitoring, Verification and Inspection Commission (UNMOVIC), Compendium of Iraq's Proscribed Weapons Programmes in the Chemical, Biological and Missile Areas (New York: United Nations, 2007), 765-1030
40. Donald Mahley, “Dismantling Libyan Weapons: Lessons Learned,” Chemical and Biological Arms Control Institute’s Arena 10 (November 2004);
41. Commission on the Intelligence Capabilities of the United States Regarding Weapons of Mass Destruction, Report to the President (Washington, DC: GPO, 2005), 253-65.
42. Defense Intelligence Agency (DIA), Proliferation of Weapons of Mass Destruction, DST-2660S-694-92, May 1992, 42.
43. R. Jeffrey Smith, “China May Have Revived Germ Weapons Program, U.S. Officials Say,” Washington Post, February 24, 1993, A4.
44. Jonathan B. Tucker, “A Farewell to Germs: The U.S. Renunciation of Biological and Toxin Warfare, 1969-70,” International Security 27, no. 1 (2002): 107-48.
45. Stanley N. Cohen, “The Manipulation of Genes,” Scientific American 233, no. 1 (July 1975): 25-33.
46. Igor V. Domaradskij and Wendy Orent, Biowarrior: Inside the Biological War Machine (Amherst, NY: Prometheus Books, 2003)
47. Christopher Davis, “Nuclear Blindness: An Overview of the Biological Weapons Programs of the Former Soviet Union and Iraq,” Emerging Infectious Diseases 5, no. 4 (1999): 509-11
48. Janet R. Gilsdorf and Raymond A. Zilinskas, “New Considerations in Infectious Disease Outbreaks: The Threat of Genetically Modified Microbes,” Clinical Infectious Diseases 40, no. 8 (2005): 1160-5.
49. Jonathan B. Tucker, Scourge: The Once and Future Threat of Smallpox (New York: Atlantic Monthly Press, 2001), 145-46, 152-55.
50. James Adams, The New Spies: Exploring the Frontiers of Espionage (London: Hutchinson, 1994), 272-73.
51. Jonathan B. Tucker, “Biological Weapons in the Former Soviet Union: An Interview with Dr. Kenneth Alibek,” Nonproliferation Review 6, no. 3 (1999): 4.
52. Joshua Lederberg and George Whitesides, Report of the Defense Science Reduction Advisory Committee Task Force on Biological Defense (Washington, DC: Office of the Under Secretary of Defense for Acquisition, Technology and Logistics, 2001), 12, 15, 120, FOIA
53. Department of Defense (DOD), Biotechnology and Genetic Engineering: Implications for the Development of New Warfare Agents (Washington, DC: GPO, 1996), 2.
54. UNMOVIC, Compendium, 849-50, 855, 918, 942
55. UNMOVIC, Unresolved Disarmament Issues: Iraq’s Proscribed Weapons Programmes (New York: United Nations, 2003), 127-28.
56. Charles Duelfer, Comprehensive Report of the Special Advisor to the DCI on Iraq's WMD, vol. 3, Biological Warfare (Langley, VA: CIA, 2004), 56-57 [hereafter Duelfer Report].
57. Chandré Gould and Peter Folb, “The Role of Professionals in the South African Chemical and Biological Warfare Programme,” Minerva 40, no. 1 (2002): 85.
58. Roger G. Breeze, Bruce Budowle, and Steven E. Schützer, eds., Microbial Forensics (Burlington, MA: Elsevier Academic Press, 2005).
59. Alexander Kelle, Malcolm Dando, and Kathryn Nixdorff, eds., The Role of Biotechnology in Countering BTW Agents (Dordrecht, Netherlands: Kluwer, 2001).
60. Stephen C. Harrison et al., “Discovery of Antivirals against Smallpox,” Proceedings of the National Academies of Science 101, no. 31 (2004): 11178-92.
61. James C. Burnett, Erik A. Henchal, Alan L. Schmaljohn, and Sina Bavari, “The Evolving Field of Biodefence: Therapeutic Developments and Diagnostics,” Nature Reviews Drug Discovery 4 (April 2005): 281-97.
62. Institute of Medicine and National Research Council, Giving Full Measure to Countermeasures: Addressing Problems in the DOD Program to Develop Medical Countermeasures against Biological Warfare Agents (Washington, DC: National Academies Press, 2004)
63. Jason Matheny, Michael Mair, Andrew Mulcahy, and Bradley T. Smith, “Incentives for Biodefense Countermeasure Development,” Biosecurity and Bioterrorism 5, no. 3 (2007): 228-38
64. Scott Gottlieb, Political Roulette and the Public Health: The Impact of Political Intrusions on Drug Development and the Consequence for America's Biodefense, AEI Working Paper 113 (Washington, DC: American Enterprise Institute, 2005).
65. DOD, Proliferation: Threat and Response (Washington, DC: GPO, 2001), 94, 113.
66. Spertzel, Wannemacher, and L. Linden, Global Proliferation, 4:11
67. David R. Franz, “Medical Countermeasures to Biological Warfare Agents,” in Role of Biotechnology in Countering BTW Agents, ed. Kelle, Dando, and Nixdorff, 228.
68. Zygmunt Debek, ed., Medical Aspects of Biological Warfare (Washington, DC: U.S. Army Surgeon General, 2007)
69. Donald A. Henderson, Thomas V. Inglesby, and Tara O’Toole, eds., Bioterrorism: Guidelines for Medical and Public Health Management (Chicago, IL: American Medical Association, 2002).
70. Edward Eitzen and Ernest Takafuji, “Historical Overview of Biological Warfare,” in Medical Aspects of Chemical and Biological Warfare, ed. Frederick R. Sidell, Ernest T. Takafuji, and David R. Franz (Falls Church, VA: U.S. Army Surgeon General, 1997), 443-44.
71. Kenneth Alibek, “Biological Weapons” (Powerpoint presentation to the United States Air Force Counterproliferation Conference, Air War College, Maxwell AFB, Alabama, November 1, 1999), http://www.globalsecurity.org/wmd/library/report/1999/alibek.ppt.
72. World Health Organization, Health Aspects of Chemical and Biological Weapons (Geneva: WHO, 1970), 96-99.
73. Office of Technology Assessment (OTA), Proliferation of Weapons of Mass Destruction: Assessing the Risks (Washington, DC: GPO, 1993), 53-54.
74. Arnold F. Kaufmann, Martin I. Meltzer, and George P. Schmid, “The Economic Impact of a Bioterrorist Attack: Are Prevention and Postattack Intervention Programs Justifiable?” Emerging Infectious Diseases 3, no. 2 (1997): 83-94.
75. OTA, Technologies Underlying Weapons of Mass Destruction (Washington, DC: GPO, 1993), 27, 86, 156-58.
76. UNMOVIC, Compendium, 793, 1055-56.
77. United Nations Secretary General, Chemical and Bacteriological (Biological) Weapons and the Effects of Their Possible Use (Geneva: United Nations, 1969), 40.
78. DOD, Chemical and Biological Defense Program: Annual Report to Congress (Washington, DC: DOD, 2007), 96.
79. DOD, Report on Biological Warfare Defense Vaccine Research and Development Programs (Fort Bel-voir, VA: Defense Technical Information Center, 2001), 2.
80. William Broad and Judith Miller, “Once He Devised Germ Weapons; Now He Defends against Them,” New York Times, November 3, 1998, D1
81. Kenneth Alibek, “Research Considerations for Better Understanding of Biological Threats,” in Institute of Medicine, Biological Threats and Terrorism: Assessing the Science and Response Capabilities (Washington, DC: National Academies Press, 2002), 64.
82. Judith Miller, Stephen Engelberg, and William Broad, Germs: Biological Weapons and America's Secret War (New York: Simon and Schuster, 2001), 297-98.
83. David Rosenbaum and David Johnston, “Single Letter with Anthrax Is Discounted,” New York Times, November 10, 2001, B1.
84. Leonard A. Cole, “WMD and Lessons from the Anthrax Attacks,” in The McGraw-Hill Homeland Security Handbook, ed. David G. Kamien (New York: McGraw-Hill, 2006), 170.
85. William C. Patrick III, “Biological Warfare Scenarios,” in, - Firepower in the Tab: Automation in the Fight against Infectious Diseases and Bioterrorism ed. Scott P. Layne, Tony J. Beugelsdijk, and C. Kumar N. Patel (Washington, DC: Joseph Henry Press, 2001), 215-23.
86. Sheryl Wu Dunn, Judith Miller, and William J. Broad, “How Japan Germ Terror Alerted the World,” New York Times, May 26, 1998, A1.
87. W. Seth Carus, “The Rajneeshees (1984),” in Jonathan B. Tucker, ed., Toxic Terror: Assessing Terrorist Use of Chemical and Biological Weapons (Cambridge: MIT Press, 2000), 115-37.
88. Gregory Koblentz, “Biological Terrorism: Understanding the Threat and the Response,” in Countering Terrorism: Dimensions of Preparedness, ed. Arnold Howitt and Robyn Pangi (Cambridge: MIT Press, 2003), 111.
89. Gregory Koblentz, “Pathogens as Weapons: The International Security Implications of Biological Weapons” (PhD diss., Massachusetts Institute of Technology, 2004), 22-23
90. Shlomo Shpiro, “Poisoned Chalice: Intelligence Use of Chemical and Biological Weapons,” International Journal of Intelligence and Counterintelligence 22, no. 1 (2009): 1-30.
91. Robert Jervis, “Cooperation under the Security Dilemma,” World Politics 30, no. 2 (1978): 205-6.
92. John J. Mearsheimer, Conventional Deterrence (Ithaca: Cornell University Press, 1983), 26.
93. Chemical Corps Board, Concepts for Employment of Antipersonnel Biological Warfare, Information Report 1 (Edgewood, MD: Chemical Corps, 1958), 12.
94. David R. Franz, “Physical and Medical Countermeasures to Biological Weapons,” Director’s Series on Proliferation 4 (Livermore, CA: Lawrence Livermore National Laboratory, May 1994), 59-60.
95. DOD, Chemical and Biological Defense Program: Annual Report to Congress and Performance Plan (Washington, DC: DOD, 2001), D-11.
96. K. Koblentz, “Biological Terrorism,” 123-43.
97. Martin I. Meltzer et al., “Modeling Potential Responses to Smallpox as a Bioterrorism Weapon,” Emerging Infectious Diseases 7, no. 6 (2001): 959-69
98. Raymond Gani and Steve Leach, “Epidemiologic Determinants for Modeling Pneumonic Plague Outbreaks,” Emerging Infectious Diseases 10, no. 4 (2004): 608-14.
99. Karl Lowe, Graham S. Pearson, and Victor Utgoff, “Potential Values of a Simple Biological Warfare Protective Mask,” in Biological Weapons: Eimitingthe Threat, ed. Joshua Lederberg (Cambridge: MIT Press, 1999), 263-81
100. Stanley L. Weiner, “Strategies for the Prevention of a Successful Biological Warfare Aerosol Attack,” Military Medicine 161, no. 5 (1996): 251-56.
101. John Martyny, Craig S. Glazer, and Lee S. Newman, “Respiratory Protection,” New England Journal of Medicine 347 (September 12, 2002): 827.
102. Lester L. Yuan, “Sheltering Effects of Buildings from Biological Weapons,” Science and Global Society 8, no. 3 (2000): 287-313
103. Richard L. Garwin, Ralph E. Gomory, and Matthew S. Meselson, “How to Fight Bioterrorism,” Washington Post, May 14, 2002, A21.
104. Institute of Medicine and National Research Council, Globalization, Biosecurity, and the Future of the Life Sciences (Washington, DC: National Academies Press, 2006).
105. DOD, Biotechnology and Genetic Engineering: Implications for the Development of New Warfare Agents (Washington, DC: GPO, 1996)
106. Steven M. Block, “Living Nightmares: Biological Threats Enabled by Molecular Biology,” in The New Terror: Facing the Threat of Biological and Chemical Weapons, ed. Sidney D. Drell, Abraham D. Sofaer, and George D. Wilson (Stanford: Hoover Institution Press, 1999), 39-75
107. Raymond Zilinskas, ed., Biological Warfare: Modern Offense and Defense (Boulder, CO: Lynne Reinner, 2000)
108. James B. Petro, Theodore R. Plasse, and Jack A. Mcnulty, “Biotechnology: Impact on Biological Warfare and Biodefense,” Biosecurity and Bioterrorism 1, no. 3 (2003): 161-68
109. British Medical Association, Biotechnology, Weapons, and Humanity II (London: British Medical Association, 2004)
110. Mark Wheelis, “Will the ‘New Biology’ Lead to New Weapons?” Arms Control Today, July/August 2004:6-13.
111. Alan Pearson, Federal Funding for Biological Weapons Prevention and Defense, Fiscal Years 2001 to 2009 (Washington, DC: Center for Arms Control and Non-Proliferation, 2008).
112. Department of State, Adherence to and Compliance with Arms Control, Nonproliferation and Disarmament Agreements and Commitments, 27-31.
113. Arms Control and Disarmament Agency, Verification: The Critical Element of Arms Control (Washington, DC: GPO, 1976), 7, 17-18
114. Matthew Meselson, “The Problem of Biological Weapons,” n.d., http://www.pugwash.org/reports/cbw/cbw5.htm
115. Julian P Perry Robinson, “Some Political Aspects of the Control of Biological Weapons,” Science in Parliament 53, no. 3 (1996): 6-11
116. Graham S. Pearson, “Biological Weapons: A Priority Concern,” Director’s Series on Proliferation 4 (Livermore, CA: Lawrence Livermore National Laboratory, May 1994), 42
117. Gradon Carter, “Biological Warfare and Biological Defence in the United Kingdom 1940-1979,” RUSI Journal 137, no. 6 (1992): 72.
118. Han Swyter, “Political Considerations and Analysis of Military Requirements for Chemical and Biological Weapons,” Proceedings of the National Academy of Sciences 65, no. 1 (1970): 261-70.
119. Thomas C. Schelling, Choice and Consequence (Cambridge: Harvard University Press, 1984), 253
120. Marie Isabelle Chevrier, “Impediment to Proliferation? Analysing the Biological Weapons Convention,” Contemporary Security Policy 16, no. 2 (1995), 84.
121. Anthony Rimmington, “The Soviet Union’s Offensive Program: The Implications for Contemporary Arms Control,” in Biological Warfare and Disarmament: New Perspectives, ed. Susan Wright (Lanham, MD: Rowman and Littlefield, 2002), 103-50.
122. SIPRI, The Problem of Chemical and Biological Warfare, 2:116.
123. U.S. Army, Employment of Chemical and Biological Agents, Army Field Manual, no. 3-10 (Washington, DC: Department of the Army, 1966), 47.
124. UNMOVIC, Unresolved Disarmament Issues, 63-64, 99, 103, 107.
125. A. Alibek, Biohazard, 29-31.
126. Eric Croddy and Sarka Krcalova, “Tularemia, Biological Warfare, and the Battle for Stalingrad (1942-1943),” Military Medicine 166, no. 10 (2001): 837-38
127. Erhard Geissler, “Alibek, Tularemia, and the Battle of Stalingrad,” CBW Conventions Bulletin 69/70 (September/December 2005): 10-15.
128. Robert Pape, Bombing to Win: Air Power and Coercion in War (Ithaca: Cornell University Press, 1996), 72.
129. Graham S. Pearson, “The Essentials of Biological Threat Assessment,” in Biological Warfare, ed. Zilinskas, 71.
130. Robert J. Larsen and Robert P. Kadlec, Biological Warfare: A Post Cold War Threat to America's Strategic Mobility Forces (Pittsburgh: Ridgway Center for Strategic Studies, 1995), 12-15.
131. Michael C. Desch, ed., Soldiers in Cities: Military Operations on Urban Terrain (Carlisle Barracks, PA: Strategic Studies Institute, October 2001).
132. John D. Steinbruner, “Biological Weapons: A Plague upon All Houses,” Foreign Policy 109 (Winter 1997-1998): 90.
133. Don T. Parker et al., Biological Vulnerability Assessment: NATO Central Front (Dugway, UT: U.S. Army Dugway Proving Ground, 1976), 2:87.
134. Timothy McCarthy and Jonathan Tucker, “Saddam’s Toxic Arsenal: Chemical and Biological Weapons in the Gulf Wars,” in Planning the Unthinkable: How New Powers Will Use Nuclear, Biological, and Chemical Weapons, ed. Peter Lavoy, Scott Sagan, and James Wirtz (Ithaca: Cornell University Press, 2000), 62.
135. Li Xiaofong, Blood-Weeping Accusations: Records of Anthrax Victims (Beijing: CCP Press, 2005)
136. Daniel Barenblatt, A Plague upon Humanity: The Hidden History of Japan’s Biological Warfare Program (New York: HarperCollins, 2004), 152-63
137. Peter Williams and David Wallace, Unit 731: Japan’s Secret Biological Warfare in World War II (New York: Free Press, 1989), 69-70.
138. Simon M. Whitby, Biological Warfare against Crops (New York: Palgrave Macmillan, 2002).
139. Terrance M. Wilson et al., “Agroterrorism, Biological Crimes, and Biological Warfare Targeting Animal Agriculture,” in Emerging Diseases of Animals, ed. Corrie Brown and Carole Bolin (Washington, DC: ASM Press, 2000), 23-57.
140. Jessica Stern, “Dreaded Risks and the Control of Biological Weapons,” International Security 27, no. 3 (2002/2003): 102-6.
141. Tom Mangold and Jeff Goldberg, Plague Wars: The Terrifying Reality of Biological Warfare (New York: St. Martin’s Press, 1999), 84-85
142. Kenneth Alibek, “The Soviet Union’s Anti-Agricultural Biological Weapons,” Annals of New York Academy of Sciences 894 (1999): 18-19
143. R. Rimmington, “The Soviet Union’s Offensive Program,” 113-15.
144. Stephen M. Meyer, “Soviet Nuclear Operations,” in Managing Nuclear Operations, ed. Ashton Carter, John Steinbruner, and Charles Zraket (Washington, DC: Brookings, 1987), 531
145. Aleksandr’ G. Savel’ev and Nikolay N. Detinov, The Big Five: Arms Control Decision-making in the Soviet Union (Westport, CT: Praeger, 1995), 1-5.
146. Gradon B. Carter and Graham S. Pearson, “British Biological Warfare and Biological Defence, 1925-1945,” in Biological and Toxin Weapons, ed. Geissler and Moon, 168-89.
147. W. Whitby, Biological Warfare against Crops, 94-117.
148. Spertzel, Wannemacher, and L. Linden, Global Proliferation, 4:12.
149. UNMOVIC, Compendium, 945-63.
150. W. Whitby, Biological Warfare against Crops, 19-21.
151. Neil C. Livingstone and Joseph D. Douglass Jr., CBW: The Poor Man's Atomic Bomb (Cambridge: Institute for Foreign Policy Analysis, 1984).
152. H. Lee Buchanan, “Poor Man’s A-Bomb?” U.S. Naval Institute Proceedings 123, no. 4 (1997): 83-8
153. Al J. Venter, “Biological Warfare: The Poor Man’s Atomic Bomb,” Jane’s Intelligence Review 11, no. 3 (1999): 42-47.
154. Steve Fetter, “Ballistic Missiles and Weapons of Mass Destruction: What is the Threat? What Should Be Done?” International Security 16, no. 1 (1991): 26.
155. Susan Martin, “The Role of Biological Weapons in International Politics: The Real Military Revolution,” Journal ofStrategic Studies 25, no. 1 (2002): 63-98.
156. Stephen Van Evera, Causes of War: Power and the Roots of Conflict (Ithaca: Cornell University Press, 2000), 244-45.
157. Bernard Brodie, “Implications for Military Policy,” in The Absolute Weapon: Atomic Power and World Order, ed. Bernard Brodie (New York: Harcourt, 1946), 76-77, 89-91.
158. Robert Jervis, The Meaning of the Nuclear Revolution (Ithaca, NY: Cornell University Press, 1989).
159. Shai Feldman, Israeli Nuclear Deterrence: A Strategy for the 1980s (New York: Columbia University Press, 1982), 32-33
160. Samuel Gladstone and Dolan J. Philip, eds., Effects of Nuclear Weapons (Washington, DC: GPO, 1977).
161. Avner Cohen and Benjamin Frankel, “Opaque Proliferation,” Journal of Strategic Studies 13, no. 3 (1990): 31-32.
162. Thomas C. Schelling and Morton H. Halperin, Strategy and Arms Control (New York: Pergamon, 1985), 37.
163. Igor V. Domaradskij and Wendy Orent, “The Memoirs of an Inconvenient Man: Revelations about Biological Weapons Research in the Soviet Union,” Critical Reviews in Microbiology 27, no. 4 (2001): 246.
164. Glenn Snyder, Deterrence and Defense (Princeton: Princeton University Press, 1961), 226.
165. Lewis Dunn, Peter Lavoy, and Scott Sagan, “Conclusions: Planning the Unthinkable,” in Planning the Unthinkable, ed. Lavoy, Sagan, and Wirtz, 234-35.
166. Kevin Woods et al., Iraqi Perspectives Project: A View of Operation Iraqi Freedom from Saddam’s Senior Leadership (Norfolk, VA: Joint Force Command, 2005), 25-28.
167. UNMOVIC, Compendium, 958.
168. UNMOVIC, Unresolved Disarmament Issues, 45-46.
169. Amatzia Baram, “An Analysis of Iraqi WMD Strategy,” Nonproliferation Review 8, no. 2 (2001): 34-36.
170. Eliot A. Cohen, Gulf War Air Power Survey, vol. 2, Effects and Effectiveness (Washington, DC: Department of the Air Force, 1993), 274-90.
171. Michael R. Gordon, “C.I.A. Fears Iraq Could Deploy Biological Arms by Early 1991,” New York Times, September 29, 1990, A4.
172. Peter Feaver, “Proliferation Optimism and Theories of Nuclear Operations,” Security Studies 2, no. 3/4 (1993): 177.
173. R. Jeffrey Smith, “UN Says Iraqis Prepared Germ Weapons in Gulf War,” Washington Post, August 26, 1995, A1.
174. Scott Sagan, “The Commitment Trap: Why the United States Should Not Use Nuclear Threats to Deter Biological and Chemical Weapon Attacks,” International Security 24, no. 4 (2000): 91-96
175. William Arkin, “Calculated Ambiguity: Nuclear Weapons and the Gulf War,” Washington Quarterly 19, no. 4 (1996): 3-18.
176. George Bush and Brent Scowcroft, A World Transformed (New York: Knopf, 1998), 442.
177. James Baker, The Politics of Diplomacy: Revolution, War, and Peace, 1989-1992 (New York: Putnam, 1995), 359.
178. Joseph Fitchett, “Nuclear States See Vindication: Threat of Annihilation Deterred Iraq, They Say,” International Herald Tribune, September 12, 1995.
179. UNMOVIC, Compendium, 788, 961-62.
180. Ali Mohamed Al-Damkhi, “Kuwait’s Oil Well Fires, 1991: Environmental Crime and War,” International Journal of Environmental Studies 64, no. 1 (2007): 31-44
181. Andrew W. Terrill, “Saddam’s Failed Counterstrike: Terrorism and the Gulf War,” Studies in Conflict and Terrorism 16, no. 3 (1993): 151-71.
182. National Intelligence Council, Iraq' Continuing Programs for Weapons of Mass Destruction, National Intelligence Estimate 2002-16HC, October 2002, 5-7.
183. John Cohen and Martin Enserink, “Rough-and-Tumble behind Bush’s Smallpox Policy,” Science 298 (December 20, 2002): 2315.
184. Leonard Cole, “The Poison Weapons Taboo: Biology, Culture, and Policy,” Politics and the Life Sciences 17, no. 2 (1998): 119-32.
185. Adrienne Mayor, Greek Fire, Poison Arrows, and Scorpion Bombs: Biological and Chemical Warfare in the Ancient World (Woodstock, NY: Overlook Press, 2003), 24-39.
186. Barry Posen, The Sources of Military Doctrine: France, Britain, and Germany between the World Wars (Ithaca, NY: Cornell University Press, 1984), 55.
187. General Accounting Office, Arms Control: U.S. and International Efforts to Ban Biological Weapons, GAO/NSIAD-93-113 (Washington, DC: GAO, 1992), 9-11.
188. Soviet Union, Egypt, and Israel and either France or the People’s Republic of China. Interdepartmental Political-Military Group, Annual Review of United States Chemical and Biological Research Programs as of July 1, 1972, October 26, 1972, p. 19.
189. Milton Leitenberg, Assessing the Biological Weapons and Bioterrorism Threat (Carlisle Barracks, PA: Strategic Studies Institute, 2005), 10-16.
190. Jonathan B. Tucker, “The Future of Biological Warfare,” in The Proliferation of Advanced Weaponry, ed. W. Thomas Wander and Eric H. Arnett (Washington, DC: American Association for the Advancement of Science, 1992), 61-71
191. Robert P. Kadlec and Alan P Zelicoff, “Implications of the Biotechnology Revolution for Weapons Development and Arms Control,” in Biological Warfare, ed. Zilinskas, 11-26.
192. Clayton Christensen, The Innovators Dilemma (Boston: Harvard Business School, 1997).
193. John Lewis Gaddis, “The Long Peace: Elements of Stability in the Postwar International System,” International Security 10, no. 4 (1986): 123-25.
194. Gordon M. Burck, “Chemical Weapons Production Technology and the Conversion of Civilian Production,” Arms Control 11, no. 12 (1990): 122-63
195. Office of Technology Assessment (OTA), Technologies Underlying Weapons of Mass Destruction (Washington, DC: GPO, 1993), 15-55.
196. Robert Jervis, “Cooperation under the Security Dilemma,” World Politics 30, no. 2 (1978): 167-214
197. Stephen Van Evera, Causes of War: Power and the Roots of Conflict (Ithaca: Cornell University Press, 2000), 135-37.
198. Susan Wright, “Geopolitical Origins,” in Biological Warfare and Disarmament: New Problems/New Perspectives, ed. Susan Wright, (Lanham, MD: Rowman and Littlefield, 2002), 313-42
199. Marie Isabelle Chevrier, “The Politics of Biological Disarmament,” in Deadly Cultures: Biological Weapons since 1945, ed. Mark Wheelis, Lajos Rozsa, and Malcolm Dando, (Cambridge: Harvard University Press, 2006), 304-28.
200. Tom Mangold and Jeff Goldberg, Plague Wars: The Terrifying Reality off Biological Warfare (New York: St. Martin’s Press, 1999), 55-57, 402 n. 26
201. Alan F. Neidle, “The Rise and Fall of Multilateral Arms Control: Choices for the United States,” in Arms Control: The Multilateral Alternative, ed. Edward C. Luck, (New York: New York University Press, 1983), 13.
202. Barend ter Haar, The Future of Biological Weapons (New York: Praeger, 1991), 64-65.
203. British Medical Association, Biotechnology, Weapons, and Humanity (Amsterdam: Harwood Academic, 1999), 37-41.
204. Raymond A. Zilinskas, “Cuban Allegations of Biological Warfare by the United States: Assessing the Evidence,” Critical Reviews in Microbiology 25, no. 3 (1999): 173-227.
205. Jonathan B. Tucker, “Multilateral Approaches to the Investigation and Attribution of Biological Weapons Use,” in Terrorism, War, or Disease? Unraveling the Use of Biological Weapons, ed. Anne L. Clunan, Peter R. Lavoy, and Susan B. Martin (Stanford: Stanford University Press, 2008), 269-92.
206. Nicholas A. Sims, The Evolution of Biological Disarmament (Oxford: Oxford University Press, 2001)
207. Jez Littlewood, The Biological Weapons Convention: A Failed Revolution (London: Ashgate, 2005).
208. Marie Isabelle Chevrier and Iris Hunger, “Confidence Building Measures for the BTWC: Performance and Potential,” Nonproliferation Review 7, no. 3 (2000): 24-42.
209. Robert J. Mathews, “The Development of the Australia Group Export Control Lists of Biological Pathogens, Toxins and Dual-Use Equipment,” CBWConventions Bulletin 66 (December 2004): 1-4.
210. Ambassador Donald Mahley, “Statement by the United States to the Ad Hoc Group of Biological Weapons Convention States Parties,” Geneva, Switzerland, July 25, 2001, http://www.state.govA/ac/rls/rm/2001/5497.htm.
211. European Federation of Pharmaceutical Industries and Associations, The Pharmaceutical Industry In Figures: 2002 (Brussels: EFPIA, 2002), 6, 13, 21.
212. Will D. Carpenter and Michael Moodie, “Industry and Arms Control,” in Biological Warfare: Modern Offense and Defense, ed. Raymond Zilinskas (Boulder, CO: Lynne Reinner, 2000), 191.
213. Jonathan B. Tucker, “The BWC New Process: A Preliminary Assessment,” Nonproliferation Review 11, no. 1 (2004): 4-8.
214. OTA, Technologies Underlying Weapons of Mass Destruction, 84-87.
215. Jonathan B. Tucker, “Dilemmas of a Dual-Use Technology: Toxins in Medicine and Warfare,” Politics and the Life Sciences 13, no. 1 (1994): 52-53.
216. Eric A. Johnson, “Clostridial Toxins as Therapeutic Agents: Benefits of Nature’s Most Toxic Proteins,” Annual Review of Microbiology 53 (1999): 551-75.
217. Alan P. Zelicoff, “The Dual-Use Nature of Biotechnology: Some Examples from Medical Therapeutics,” Director’s Series on Proliferation 4 (Livermore, CA: Lawrence Livermore National Laboratory, May 1994), 82-83.
218. United Nations Monitoring, Verification and Inspection Commission (UNMOVIC), Unresolved Disarmament Issues: Iraq’s Proscribed Weapons Programmes (New York: United Nations, 2003), 131-32.
219. National Research Council, Seeking Security: Pathogens, OpenAccess, and Genome Databases (Washington, DC: National Academies Press, 2004), 3.
220. Steven M. Block, “Living Nightmares: Biological Threats Enabled by Molecular Biology,” in The New Terror: Facing the Threat of Biological and Chemical Weapons, ed. Sidney D. Drell, Abraham D. So-faer, and George D. Wilson (Stanford, CA: Hoover Institution Press, 1999), 60-65.
221. Ronald J. Jackson, et al., “Expression of Mouse Interleukin-4 by a Recombinant Ectromelia Virus Suppresses Cytolytic Lymphocyte Responses and Overcomes Genetic Resistance to Mousepox,” Journal of Virology 75, no. 3 (2001): 1205-10.
222. Ken Alibek, Biohazard: The Chilling True Story of the Largest Covert Biological Weapons Program in the World-Told from the Inside by the Man Who Ran It, with Stephen Handelman (New York: Random House, 1999), 231.
223. Milton Leitenberg, “Distinguishing Offensive from Defensive Biological Weapons Research,” Critical Reviews in Microbiology 29, no. 3 (2003): 232-34.
224. Raymond A. Zilinskas, “Verifying Compliance to the Biological and Toxin Weapons Convention,” Critical Reviews in Microbiology 24, no. 3 (1998): 198.
225. Tim Trevan, Saddam's Secrets: The Huntfor Iraq's Hidden Weapons (London: HarperCollins, 1999), 314
226. Gregory Koblentz, “Countering Dual-Use Facilities: Lessons from Iraq and Sudan,” Jane’s Intelligence Review 11, no. 3 (1999): 48-53.
227. Chandré Gould, and Peter Folb, “The South African Chemical and Biological Warfare Program: An Overview,” Nonproliferation Review 7, no. 3 (Fall/Winter 2000): 14.
228. A. V. Stepanov, et al., “Development of Novel Vaccines against Anthrax in Man,” Journal of Biotechnology 44 (1996): 155-60
229. A. P. Pomerantsev, et al., “Expression of Cereolysine AB Genes in Bacillus Anthracis Vaccine Strain Ensures Protection against Experimental Hemolytic Anthrax Infection,” Vaccine 15, no. 17/18 (1997): 1846-50.
230. Stockholm International Peace Research Institute (SIPRI), The Problem of Chemical and Biological Warfare, vol. 2, CB Weapons Today (New York: Humanities Press, 1973), 163-64.
231. William Broad and Judith Miller, “Government Report Says 3 Nations Hide Stocks of Smallpox,” New York Times, June 13, 1999, A1.
232. Charles Duelfer, Comprehensive Report of the Special Advisor to the DCI on Iraq's WMD, vol. 3, Biological Warfare (Langley, VA: CIA, 2004), 3 [hereafter Duelfer Report].
233. National Security Council, “United States Policy on Chemical Warfare Program and Bacterio-logical/Biological Research Program,” National Security Decision Memorandum 35, November 25, 1969, p. 3, FOIA.
234. Marléne Burger and Chandré Gould, Secrets and Lies: Wouter Basson and South Africa’s Chemical and Biological Warfare Programme (Cape Town, S. A.: Zebra Press, 2002), 183.
235. Charles Piller and Keith R. Yamamoto, Gene Wars: Military Control over the New Genetic Technologies (New York: Morrow, 1988)
236. Susan Wright and Stuart Ketcham, “The Problem of Interpreting the U.S. Biological Defense Research Program,” in Preventing a Biological Arms Race, ed. Susan Wright, (Cambridge: MIT Press, 1990), 169-96.
237. James B. Petro and W. Seth Carus, “Biological Threat Characterization Research: A Critical Component of National Biodefense,” Biosecurity and Bioterrorism 3, no. 4 (2005): 295-308.
238. Milton Leitenberg, James Leonard, and Richard Spertzel, “Biodefense Crossing the Line,” Politics and the Life Sciences 22, no. 2 (2004): 1-2
239. Lois R. Ember, “Testing the Limits,” Chemical and Engineering News 83 (August 15, 2005): 26-32.
240. Marie Isabelle Chevrier, “Verifying the Unverifiable: Lessons from the Biological Weapons Convention,” Politics and the Life Sciences 9, no. 1 (1990): 99
241. Malcolm Dando, Biological Warfare in the 21st Century: Biotechnology and the Proliferation of Biological Weapons (London: Brassey’s, 1994), 190.
242. Department of Defense, Biotechnology and Genetic Engineering: Implicationsfor the Development of New Warfare Agents (Washington, DC: DOD, 1996), 4-7
243. Judith Miller, Stephen Engelberg, and William J. Broad, “U.S. Germ Warfare Research Pushes Treaty Limits,” New Yorf Times, September 4, 2001, A1
244. Judith Miller, Stephen Engelberg, and William Broad, Germs: Biological Weapons and Americ a's Secret War (New York: Simon and Schuster, 2001), 290-298, 308-10
245. Judith Miller, “When Is a Bomb Not a Bomb? Germ Experts Confront U.S.,” New York Times, September 5, 2001, A5
246. Elisa Harris, “Research Not to Be Hidden,” New York Times, September 6, 2001
247. Barbara Hatch Rosenberg and Milton Leitenberg, “Who’s Afraid of a Germ Warfare Treaty?” Los Angeles Times, September 6, 2001
248. Mark Wheelis and Malcolm Dando, “Back to Bioweapons,” Bulletin of the Atomic Scientists 59, no. 1 (2003): 40-46.
249. Robert P. Kadlec and Randall J. Larsen, “Passive Defense,” in Countering the Proliferation and Use of Weapons of Mass Destruction, ed. Peter L. Hays, Vincent J. Jodoin, and Alan R. Van Tassel, (New York: McGraw-Hill, 1998), 232.
250. Joby Warrick, “The Secretive Fight against Bioterror,” Washington Post, July 30, 2006, A1.
251. Department of Commerce, A Survey of the Use of Biotechnology in U.S. Industry (Washington, DC: Department of Commerce, 2003), 73, 76-77.
252. Gillian R. Woollett, “Industry’s Role, Concerns, and Interests in the Negotiations of a BWC Compliance Protocol,” in Marie I. Chevrier, et al., Biological Weapons Proliferation: Reasonsfor Concern, Courses of Action (Washington, DC: Henry L. Stimson Center, 1998), 41.
253. Joseph A. DiMasi and Henry G. Gabrowski, “The Cost of Biopharmaceutical R&D: Is Biotech Different?” Managerial and Decision Economics 28 (2007): 469-79.
254. Dane Zabriskie, “Strengthening the Biological Weapons Convention and Implications on the Pharmaceutical Industry and Biotechnology Industry,” Current Opinion in Biotechnology 9 (1998): 313
255. Al Homberg, “Industry Concerns Regarding Disclosure of Proprietary Information,” Director’s Series on Proliferation 4 (Livermore, CA: Lawrence Livermore National Laboratory, May 1994), 93-97.
256. Robert F. Service, “Surviving the Blockbuster Syndrome,” Science 303 (March 19, 2004): 1796-99.
257. Sharon Mollman Elliott, “The Threat from Within: Trade Secret Theft by Employees,” Nature Biotechnology 25, no. 3 (2007): 293-95
258. Douglas Pasternak, “In the DNA Vials, Secrets to Steal,” U.S. News & World Report, May 21, 2001, 42
259. Richard Behar, “Drug Spies,” Fortune, September 6, 1999, 230-41.
260. Raymond A. Zilinskas, “Iraq’s Biological Weapons: The Past as Future?” in Biological Weapons: Limiting the Threat, ed. Joshua Lederberg (Cambridge: MIT Press, 1999), 138-40.
261. Peter Hambleton, et al., “A High Containment Polymodal Pilot-Plant Fermenter: Design Concepts,” Journal of Chemical Technology Biotechnology 50, no. 2 (1991): 167-80.
262. Richard O. Spertzel, Robert W. Wannemacher, and Carol D. Linden, Global Proliferation: Dynamics, Acquisition Strategies, and Responses, vol. 4, Biological Weapons Proliferation (Washington, DC: Defense Nuclear Agency, 1994): 22, 27.
263. OTA, Technologies Underlying Weapons of Mass Destruction, 49, 106, 164.
264. Jean Krasno and James Sutterlin, The United Nations and Iraq: Defanging the Viper (Westport, CT: Praeger, 2003), 66.
265. Spertzel, Wannemacher, and L. Linden, Global Proliferation, 4:42.
266. Robert P. Kadlec, Allan P Zelicoff, and Ann M. Vrtis, “Biological Weapons Control: Prospects and Implications for the Future,” in Biological Weapons, ed. Lederberg, 96
267. Edward J. Lacey, “The UNSCOM Experience,” Arms Control Today August 1996:11
268. Kathleen C. Bailey, The UN Inspections in Iraq: Lessons for On-Site Verification (Boulder, CO: Westview Press, 1995), 48.
269. Graham S. Pearson, The UNSCOM Saga: Chemical and Biological Weapons Non-Proliferation (New York: St. Martin’s Press, 1999), 203-5.
270. Karen Jansen, “Biological Weapons Proliferation,” in Multilateral Verification and the Post-Gulf Environment: Learning from the UNSCOM Experience, ed. Steven Mataija and J. Marshall Beier (Toronto: York University, 1992), 113.
271. Jonathan B. Tucker, “Lessons of Iraq’s Biological Warfare Programme,” Arms Control 14, no. 3 (1993): 254.
272. T. Tucker, “Lessons of Iraq’s Biological Warfare Programme,” 256.
273. Milton Leitenberg, The Problem of Biological Weapons (Stockholm: Swedish National Defence College, 2004), 198
274. General Accounting Office, Arms Control: U.S. and International Efforts to Ban Biological Weapons, GAO/NSIAD-93-113 (Washington, DC: GAO, 1992), 56.
275. J. Jansen, “Biological Weapons Proliferation,” 114.
276. B. Bailey, UN Inspections in Iraq, 41.
277. Gordon Vachon, “Chemical and Biological Weapons: Working Group Summary,” in Multilateral Verification, ed. Mataija and Beier, 128
278. B. Bailey, UN Inspections in Iraq, 42-43.
279. J. Jansen, “Biological Weapons Proliferation,” 113.
280. United Kingdom, UN Special Commission BW Inspections in Iraq: Lessons for the Ad Hoc Experts Group on Verification, BWC/CONF.III/VEREX.WP5, 1992, 5.
281. David L Huxsoll, “The Nature and Scope of the BW Threat,” Directors Series on Proliferation 4 (Livermore, CA: Lawrence Livermore National Laboratory, May 1994), 27.
282. Paul Lewis, “UN Weapons Inspectors Renew Hunt in Iraq,” New York Times, November 17, 1991, A12.
283. UNMOVIC, Compendium of Iraq's Proscribed Weapons Programmes in the Chemical, Biological and Missile Areas (New York: United Nations, 2007), 827-32, 915-23, 937-40 [hereafter Compendium].
284. Rod Barton, The Weapons Detective: The Inside Story of Australia's Top Weapons Inspector (Melbourne: Black Inc. Agenda, 2006), 81-92.
285. Central Intelligence Agency (CIA), Intelligence Related to Possible Sources of Biological Agent Exposure during the Persian Gulf War (Langley, VA: CIA, August 2000), http://www.gulflink.osd.mil/library/43917.htm.
286. Graham S. Pearson, The Search for Iraq’s Weapons of Mass Destruction (London: Palgrave Macmillan, 2005), 43.
287. Stephen Black, “Investigating Iraq’s Biological Weapons Program,” in Biological Weapons, ed. Lederberg, 164.
288. John Barry, “Unearthing the Truth,” Newsweek, March 2, 1998, 40.
289. Charles Duelfer, “The Inevitable Failure of Inspections in Iraq,” Arms Control Today September 2002:11.
290. Rolf Ekeus, Iraq’s Biological Weapons Program: UNSCOM's Experience (New York: United Nations, November 20, 1996), 3.
291. James Bone, “Chemical Agents,” Times of London, December 13, 1997
292. William Broad and Judith Miller, “Iraq’s Deadliest Arms: Puzzles Breed Fear,” New York Times, February 26, 1998, A1.
293. Richard O. Spertzel, “Sampling and Analysis as a Monitoring Tool: Lessons from the UNSCOM Experience,” in The Utility of Sampling and Analysis for Compliance Monitoring of the Biological Weapons Convention, ed. Jonathan B. Tucker, (Livermore, CA: Lawrence Livermore National Laboratory and Monterey Institute for International Studies, 1997), 22-23.
294. Margaret Sloane, “UNSCOM’s Inspections for Biological Weapons in Iraq, 1991-1998” (master’s thesis, Fletcher School, Tufts University, 2002), 18-21.
295. Rolf Ekeus, “UN Biological Inspections in Iraq,” in The New Terror, ed. Drell, Sofaer, and Wilson, 245-46.
296. UNMOVIC, Compendium, 1134-35.
297. Raymond A. Zilinskas, “Detecting and Deterring Biological Weapons: Lessons from United Nations Special Commission (UNSCOM) Operations in Iraq,” in Arms Control in a Multi-Polar World, ed. James Brown, (Amsterdam: VU University Press, 1996).
298. Alan J. Mohr, “Biological Sampling and Analysis Procedures for the United Nations Special Commission (UNSCOM) in Iraq,” Politics and the Life Sciences 14, no. 2 (1995): 240-43.
299. Amatzia Baram, Building toward Crisis: Saddam Husayn's Strategyfor Survival (Washington, DC: Washington Institute for Near East Policy, 1998), 8-13.
300. Scott Ritter, Endgame: Solving the Iraq Problem Once and For All (New York: Simon and Schuster, 1999), 76-93.
301. Kenneth Timmerman, The Death Lobby: How the West Armed Iraq (Boston, MA: Houghton Mifflin, 1991), 36, 257-58, 288.
302. William J. Broad and Judith Miller, “Germs, Atoms and Poison Gas: The Iraqi Shell Game,” New York Times, December 20, 1998, WK5.
303. Stephen Black, “Verification under Duress: The Case of UNSCOM,” in Verification Yearbook 2000, ed. Trevor Findlay, (London: VERTIC, 2000), 121.
304. Rolf Ekeus, “Yes, Let’s Go into Iraq,” Washington Post, September 15, 2002, B1.
305. Barton Gellman, “Iraq’s Arsenal Was Only on Paper,” Washington Post, January 7, 2004, A1.
306. B. Barton, Weapons Detective, 162-63. 181.
307. Stephen Morse, “Detecting Biological Warfare Agents,” in Biological Warfare, ed. Zilinskas, 98
308. Kay Mereish, “Technical Advances and Field Experiences for Use in Biological Verification,” (paper presented to the NGO Committee on Disarmament, Peace and Security, UN Headquarters, New York City, New York, April 19, 2007), http://disarm.igc.org/unmovic19april.pdf.
309. Meghan L. O’Sullivan, Shrewd Sanctions: Statecraft and State Sponsors of Terrorism (Washington, DC: Brookings, 2003), 168.
310. UNSC, Plan for Future Ongoing Monitoring and Verification of Iraq's Compliance with Relevant Parts of Section C of Security Council Resolution 687 (1991), S/22871/Rev. 1 (New York: United Nations, October 2, 1991), 9-11, 26-28.
311. Leonard A. Cole, “The Poison Weapons Taboo: Biology, Culture, and Policy,” Politics and the Life Sciences 17, no. 2, (1998): 119-32
312. John Ellis van Courtland Moon, “Controlling Chemical and Biological Weapons through World War II,” in.encyclopedia ofArms Control and Disarmament, vol. 2, ed. Richard Burns (New York: Scribner’s Sons, 1993), 657-74.
313. Barton J. Bernstein, “America’s Biological Warfare Program in the Second World War,” Journal of Strategic Studies 11, no. 3 (1988): 294.
314. United Kingdom Foreign Office, Arms Control and Disarmament Research Unit, “The Arms Control Implications of Chemical and Biological Weapons: Analysis and Proposals,” ACDRU 66(2), 2d draft, July 4, 1966, p. 25, FO 371/187448, National Archives, Kew, United Kingdom.
315. Judith Miller, Stephen Engelberg, and William Broad, Germs: Biological Weapons and America's Secret War (New York: Simon and Schuster, 2001), 222.
316. Tom Mangold and Jeff Goldberg, Plague Wars: The Terrifying Reality off Biological Warfare (New York: St. Martin’s Press, 1999), 65, 182.
317. Valentin Bojtzov and Erhard Geissler, “Military Biology in the USSR, 1920-1945,” in Biological and Toxin Weapons: Research, Development and Usefrom the Middle Ages to 1945, ed. Erhard Geissler and John Ellis van Courtland Moon (Oxford: Oxford University Press, 1999), 153-67.
318. Ken Alibek, Biohazard: The Chilling True Story of the Largest Covert Biological Weapons Program in the World- Told from the Inside by the Man Who Ran It, with Stephen Handelman (New York: Random House, 1999), 33-35, 92-93.
319. Anthony Rimmington, “The Soviet Union’s Offensive Program,” in Biological Warfare and Disarmament, ed. Susan Wright (Lanham, MD: Rowman and Littlefield, 2002), 113-15, 122-23.
320. Igor V. Domaradskij and Wendy Orent, Biowarrior: Inside the Soviet/Russian Biological War Machine (Amherst, NY: Prometheus Books, 2003), 135.
321. D. Domaradskij and O. Orent, “The Memoirs of an Inconvenient Man,” Critical Reviews in Microbiology 27, no. 4 (2001): 251.
322. Jonathan B. Tucker, Scourge: The Once and Future Threat of Smallpox (New York: Atlantic Monthly Press, 2001), 151.
323. Chandré Gould and Peter Folb, Project Coast: Apartheid's Chemical and Biological Warfare Programme (Geneva: United Nations, 2002), 72.
324. Marléne Burger and Chandré Gould, Secrets and Lies: Wouter Basson and South Africa's Chemical and Biological Warfare Programme (Cape Town, S. A.: Zebra Press, 2002), 13, 20
325. Avner Cohen and Benjamin Frankel, “Opaque Proliferation,” Journal of Strategic Studies 13, no. 3 (1990): 22, 34.
326. Peter Feaver, “Proliferation Optimism and Theories of Nuclear Operations,” Security Studies 2, no. 3/4 (1993): 175-78.
327. Peter D. Feaver, Armed Servants: Agency, Oversight, and Civil-Military Relations (Cambridge: Harvard University Press, 2003), 68-71.
328. Barry Posen, The Sources of Military Doctrine: France, Britain, and Germany between the World Wars (Ithaca: Cornell University Press, 1984), 45.
329. Gregory Koblentz, “Countering Dual-Use Facilities: Lessons from Iraq and Sudan,” Janes Intelligence Review 11, no. 3 (1999): 48-53.
330. Amy Smithson, Toxic Archipelago: Preventing Proliferation from the Former Soviet Chemical and Biological Weapons Complexes (Washington, DC: Henry L. Stimson Center, 1999), 9.
331. Carolyn M. Ekedahl and Melvin A. Goodman, The Wars of Eduard Shevardnadze (University Park: Pennsylvania State University Press, 1997)
332. William C. Green and Theodore Karasik, eds., Gorbachev and His Generals: The Reform of Soviet Military Doctrine (Boulder, CO: Westview Press, 1990).
333. R. Jeffrey Smith, “Yeltsin Blames’79 Anthrax on Germ Warfare Efforts,” Washington Post, June 16, 1992, A1.
334. James Adams, The New Spies: Exploring the Frontiers of Espionage (London: Hutchinson, 1994), 272-73.
335. Simon Cooper, “Life in the Pursuit of Death,” Seed 4 (January/February 2003): 104.
336. Bill Gertz, “Defecting Russian Scientist Revealed Biological Arms Efforts,” Washington Times, July 4, 1992, A4
337. R. Jeffrey Smith, “Russia Fails to Detail Germ Arms,” Washington Post, August 31, 1992, A1.
338. Mark Urban, UK Eyes Alpha: Inside British Intelligence (London: Faber and Faber, 1996), 132-33.
339. Judith Miller, “At Bleak Asian Site, Killer Germs Survive,” New York Times, June 2, 1999, A1
340. Jonathan B. Tucker, “Biological Weapons in the Former Soviet Union: An Interview with Dr. Kenneth Alibek,” Nonproliferation Review 6, no. 3 (1999): 6.
341. James A. Baker III, The Politics of Diplomacy: Revolution, War, and Peace, 1989-1992 (New York: Putnam, 1995), 621.
342. David C. Kelly, “The Trilateral Agreement: Lessons for Biological Weapons Verification,” in Verification Yearbook 2002, ed. Trevor Findlay and Oliver Meier (London: VERTIC, 2002), 96.
343. R. Jeffrey Smith, “U.S. Officials Allege That Russians Are Working on Biological Arms,” Washington Post, April 8, 1994, A28
344. Sergei Shargorodsky, “Former Chemical Weapons Chief Investigated for Chemical Smuggling,” Associated Press, October 23, 1995
345. Department of State, “Imposition of Chemical and Biological Weapons Proliferation Sanctions on a Foreign Person,” Federal Register 60, no. 234 (1995): 62526-27.
346. Russian Federation, “Declaration of Past Activity in Regard to Offensive and Defensive Programs of Biological Research and Development,” United Nations Form F, DDA/4-92/BWIII, 1992.
347. R. Jeffrey Smith, “Russia Fails to Detail Germ Arms,” Washington Post, August 31, 1992, A1.
348. Anthony Rimmington, “Fragmentation and Proliferation? The Fate of the Soviet Union’s Offensive Biological Weapons Programme,” Contemporary Security Policy 20, no. 1 (1999): 91.
349. Wendy Orent, Plague: The Mysterious Past and Terrifying Future of the World's Most Dangerous Disease (New York: Free Press, 2004), 229.
350. Judith Miller, “Official Confirms 1995 Russian-Iraq Deal,” New York Times, February 18, 1998, A8.
351. R. Jeffrey Smith, “Russians Admit Firms Met Iraqis,” Washington Post, February 18, 1998, A16.
352. R. Jeffrey Smith, “Did Russia Sell Iraq Germ Warfare Equipment?” Washington Post, February 12, 1998, A1.
353. Richard O. Spertzel before the House Armed Services Committee, State of the Iraqi Weapons of Mass Destruction Program, 107 th Cong., 2nd sess., September 10, 2002.
354. Charles Duelfer, Comprehensive Report of the Special Advisor to the DCI on Iraq's WMD, vol. 3, Biological Warfare (Langley, VA: CIA, 2004), 13-14 [hereafter Duelfer Report].
355. United Nations Monitoring, Verification and Inspection Commission, Compendium of Iraq's Proscribed Weapons Programmes in the Chemical, Biological and Missile Areas (New York: UNMOVIC, 2007), 1025.
356. James Adams, “Russia’s Secret Weapons for Germ Warfare,” Sunday Times (London), March 27, 1994.
357. Wendy Orent, “Escape from Moscow,” The Sciences 38, no. 3 (1998): 30.
358. Department of Defense, Report to Congress on Biological Weapons Programs in Russia (Washington: DOD, January 11, 2000), 2.
359. Department of State, Adherence to and Compliance with Arms Control, Nonproliferation, and Disarmament Agreements and Commitments (Washington, DC: Department of State, 2005), 27-31.
360. Truth and Reconciliation Commission (TRC), Truth and Reconciliation Commission of South Africa Report, vol. 2 (Basingstoke, UK: Macmillan Reference, 1999), 522.
361. Princeton N. Lyman, Partner to History: The U.S. Role in South Africa's Transition to Democracy (Washington, DC: United States Institute of Peace Press, 2002), 190.
362. TRC, Truth and Reconciliation Commission of South Africa Report, vol. 2, 511.
363. D. P. Knobel, “Briefing to President Mandela on the Defensive Chemical and Biological Warfare Programme of the SADF and the RSA’s Position with Regard to the CWC and BWC,” CG/UG/302/J1282/5, August 18, 1994, 3, http://cryptome.org/mandela-cbw.htm.
364. South Africa, Confidence Building Measure F: Declaration of Past Activities, December 15, 1993, cited in Gould and Folb, Project Coast, 100-101, 213-14.
365. Nicolas Isla, Transparency in Past Offensive Biological Weapon Programmes: An Analysis of Confidence Building Measure Form F, 1992-2003 (Hamburg: Hamburg Center for Biological Arms Control, 2006), 18-19.
366. Joby Warrick, “Biotoxins Fall into Private Hands,” Washington Post, April 21, 2003, A1.
367. James Adams, “Gadaffi Lures South Africa’s Top Germ Warfare Scientists,” Sunday Times, February 26, 1995
368. Paul Taylor, “Toxic S. African Arms Raise Concern,” Washington Post, February 28, 1995, A14.
369. Robert Block, “Bitter Researchers Are Big Question in Germ Warfare,” Wall Street Journal, May 20, 2002, A1.
370. Michael Moodie, “The Soviet Union, Russia, and the Biological and Toxin Weapons Convention,” Nonproliferation Review 8, no. 1 (2001): 65-67.
371. Rod Barton, Weapons Detective: The Inside Story of Australia's Top Weapons Inspector (Melbourne: Black Inc. Agenda, 2006), 239.
372. Jonathan B. Tucker, “A Farewell to Germs: The U.S. Renunciation of Biological and Toxin Warfare, 1969-70,” International Security 27, no. 1 (2002): 107-48.
373. Milton Leitenberg, Assessing the Biological Weapons and Bioterrorist Threat (Carlisle Barracks, PA: Strategic Studies Institute, 2005), 54-55, 59-70, 84.
374. Judith Miller, “When Is a Bomb Not a Bomb? Germ Experts Confront U.S.,” New York Times, September 5, 2001, A5.
375. Elisa Harris, “Research Not to Be Hidden,” New York Times, September 6, 2001
376. Malcolm R. Dando and Mark Wheelis “Back to Bioweapons?” Bulletin of the Atomic Scientists 59, no. 1 (2003): 41-45.
377. National Intelligence Council (NIC), Iraq's Continuing Programs for Weapons of Mass Destruction: Key Judgments, NIE 2002-16HC, October 2002, 6, http://www.dni.gov/nic/special_keyjudgements.html.
378. Charles Duelfer, Comprehensive Report of the Special Advisor to the DCI on Iraq's WMD, vol. 3, Biological Warfare (Langley, VA: CIA, 2004) [hereafter Duelfer Report].
379. Lawrence Freedman, U.S. Intelligence and the Soviet Threat (Princeton: Princeton University Press, 1986), 188.
380. Bill Gertz, “Defecting Russian Scientist Revealed Biological Arms Efforts,” Washington Times, July 4, 1992, A4
381. R. Jeffrey Smith, “Russia Fails to Detail Germ Arms,” Washington Post, August 31, 1992, A1.
382. Central Intelligence Agency (CIA), The Soviet BW Program: Scientific Intelligence Research Aid, OSI-RA/61-3, Office of Scientific Intelligence, April 24, 1961, 1, Freedom of Information Act [hereafter FOIA].
383. Erhard Geissler, “Biological Warfare Activities in Germany, 1923-1945,” in Biological and Toxin Weapons: Research, Development and Use from the Middle Ages to 1945, ed. Erhard Geissler and John Ellis van Courtland Moon (Oxford: Oxford University Press, 1999), 97.
384. Walter Hirsch, Soviet BW and CW Preparations and Capabilities (Washington, DC: U.S. Army Chemical Intelligence Branch, May 1951), 101-13.
385. Wilton E. Lexow and Julian Hoptman, “The Enigma of Soviet BW,” Studies in Intelligence 9 (Spring 1965): 15-16.
386. CIA, Soviet BW Program, vol iii, 68, 77, 83-84.
387. J. J. Bagnall, “The Exploitation of Russian Scientific Literature for Intelligence Purposes,” Studies in Intelligence (Summer 1958): 45-49, FOIA.
388. CIA, Soviet BWProgram, vol iii, 3, 8, 54.
389. CIA, Soviet Capabilities and Intentions with Respect to Biological Warfare, NIE 11-6-64, August 26, 1964, 1, Declassified Document Reference Service.
390. CIA, Soviet Capabilities and Intentions, 2.
391. Gulbarshyn Bozheyeva, Yerlan Kunakbayev, and Dastan Yeleukenov, Former Soviet Biological Weapons Facilities in Kazakhstan: Past Present and Future, Occasional Paper 1 (Monterey, CA: Center for Nonproliferation Studies, 1999), 5-7.
392. Mark M. Lowenthal, Intelligence: From Secrets to Policy (Washington, DC: CQ Press, 2003), 8.
393. Dino A. Brugioni, “Photo Interpretation in the 1950s,” in Early Cold War Overflights, 1950-1956 Symposium Proceedings, vol. 1, Memoirs, ed. R. Cargill Hall and Clayton D. Laurie (Washington, DC: National Reconnaissance Office, 2003), 315.
394. CIA, Soviet Capabilities and Intentions, 2-4.
395. CIA, Soviet Capabilities and Intentions, 2-4.
396. CIA, Soviet Chemical and Biological Warfare Capabilities, NIE 11-11-69, February 13, 1969, 10, FOIA.
397. Jan Sejna, We Will Bury You (London: Sidgwick and Jackson, 1982), 32-34, 109.
398. Joseph D. Douglass Jr., “The Expanding Threat of Chemical-Biological Warfare: A Case of U.S. Tunnel Vision,” Strategic Review (Fall 1986): 42-43.
399. Foreign Capabilities Task Force, “The Nature of the Threat to the U.S. and its Allies,” September 29, 1969, 3, FOIA.
400. CIA, Soviet Chemical and Biological Warfare Capabilities, 9-10.
401. Forrest Russell Frank, “U.S. Arms Control Policymaking: The 1972 Bacteriological Treaty Case” (PhD diss., Stanford University, 1974), 180.
402. Stockholm International Peace Research Institute, Problem of Chemical and Biological Warfare, vol. 2, CB Weapons Today (New York: Humanities Press, 1973), 174.
403. Interdepartmental Political-Military Working Group, Annual Review of United States Chemical Warfare and Biological Research Programs as of 1 November 1970, 19, FOIA.
404. Anthony Rimmington, “From Offence to Defence? Russia’s Reform of its Biological Weapons Complex and the Implications for Western Security,” Journal of Slavic Military Studies 16, no. 1 (2003): 12-15.
405. R. N. Lukina, E. P. Lukin, and V. K. Bulavko, eds., Dostoiny Izvestnosti: 50 let Tsentru Ministerstva Oborony [Worthy of fame: 50 years of the Ministry of Defense’s Virology Center] (Sergiev Posad, Russia: Ves’ Sergiev Posad, 2004).
406. Ken Alibek, Biohazard: The Chilling True Story of the Largest Covert Biological Weapons Program in the World-Told from the Inside by the Man Who Ran It, with Stephen Handelman (New York: Random House, 1999), 51-52, 59-61.
407. CIA, Soviet BWProgram, vol iii, 3, 8, 54.
408. Scientific Estimates Committee, Estimate of Soviet Biological Warfare Capabilities through 1960, SEC 2-54, April 20, 1954, 14-33, FOIA.
409. CIA, Soviet BW Program, vol iii, 3, 8, 54
410. Anthony Rimmington, “The Soviet Union’s Offensive Program: The Implications for Contemporary Arms Control,” in Biological Warfare and Disarmament, ed. Susan Wright (Lanham, MD: Rowman and Littlefield, 2002), 113-15.
411. Kenneth Alibek, “The Soviet Union’s AntiAgricultural Biological Weapons,” Annals of New York Academy of Sciences 894 (1999): 18-19
412. Igor V. Domaradskij and Wendy Orent, “Achievements of the Soviet Biological Weapons Programme and Implications for the Future,” Scientific and Technical Review 25, no. 1 (2006): 157.
413. Valentin Bojtzov and Erhard Geissler, “Military Biology in the USSR, 1920-1945,” in Biological and Toxin Weapons: ed. Geissler and Moon, 153-67.
414. Christopher Davis, “Plague War: Interview with Christopher Davis,” Frontline, PBS, July 1998, http://www.pbs.org/wgbh/pages/frontline/shows/plague/interviews/davis.html.
415. Raymond L. Garthoff, “Polyakov’s Run,” Bulletin of the Atomic Scientists 56, no. 5 (2000): 37-40.
416. Russian Federation, “Declaration of Past Activity,” 52-53.
417. William Beecher, “Soviets Feared Violating Germ Weapons Ban,” Boston Globe, September 28, 1975, 1.
418. Don T. Parker, Dale O. Galloway, and J. Clifton Spendlove, Defense against Biological Attack: A General Assessment, Dugway Proving Ground, May 1975, 15, NSA.
419. DIA, Chemical and Biological Warfare Capabilities--USSR, DST-1600S-034-76-SUP-1, March 1976, 5-7, NSA.
420. William Beecher, “Logging Arms Tests Crucial,” Boston Globe, October 15, 1976.
421. House Permanent Select Committee On Intelligence (HPSCI), Soviet Biological Warfare Activities (Washington, DC: GPO, 1980), 3.
422. Leslie H. Gelb, “Keeping an Eye on Russia,” New Times Magazine, November 29, 1981, 33.
423. DIA, USSR: Biological Warfare, 2.
424. CIA, Soviet Biological Warfare Agent: Probable Cause of the Anthrax Epidemic in Sverdlovsf, January 16, 1980, http://www.gwu.edu/~nsarchiv/NSAEBB/NSAEBB61/Sverd4.pdf.
425. DIA, USSR: Biological Warfare, 3-4.
426. Elisa Harris, “Sverdlovsk and Yellow Rain: Two Cases of Soviet Noncompliance?” International Security 11, no. 4 (1987): 49.
427. DIA, USSR: Biological Warfare, 4
428. R. Jeffrey Smith, “Yeltsin Blames’79 Anthrax on Germ Warfare Efforts,” Washington Post, June 16, 1992, A1.
429. William Kucewicz, “The Science of Snake Venom,” Wall Street Journal, April 25, 1984
430. William Kucewicz, “A Non-Stop Russian Response to WWI,” Wall Street Journal, May 10, 1984.
431. Gary Thatcher, “Disease as an Agent of War,” Christian Science Monitor, December 15, 1988, B1.
432. DIA, Biological Warfare Capabilities-Warsaw Pact, 12.
433. Jack Anderson and Dale Van Atta, “Poison and Plague: Russia’s Secret Terror Weapons,” Readers Digest, September 1984, 56.
434. Russian Federation, “Declaration of Past Activity,” 55.
435. National Foreign Assessment Center, Soviet Recombinant DNA Research: Status and Trends, September 1978, FOIA.
436. DOD, Soviet Military Power (Washington, DC: GPO, 1981), 79
437. Sonia Ben Ouagrham and Kathleen M. Vogel, Conversion at Stepnogorsk: What the Future Holds for Former Bioweapons Facilities, Occasional Paper 28 (Ithaca: Cornell University Peace Studies Program, February 2003).
438. Kenneth Alibek, “Biological Weapons,” (Powerpoint presentation at the United States Air Force Counterproliferation Conference, Air War College, Maxwell AFB, Alabama, November 1, 1999).
439. T. Tucker, “Biological Weapons in the Former Soviet Union,” 2
440. Gary Crocker, “Plague Wars: Interview with Gary Crocker,” Frontline, PBS, July 1998, http://www.pbs.org/wgbh/pages/frontline/shows/plague/interviews/crocker.html.
441. Albert J. Mauroni, Chemical-Biological Defense: U.S. Military Policies and Decisions in the Gulf War (Westport, CT: Praeger, 1998), 75, 87.
442. DIA, Iraq’s Chemical and Biological Warfare Capabilities: Surviving Assets and Lacf of Use during the War, DIM 88-91, March 1991, 2, FOIA.
443. Stephen Engelberg, “Iraq Said to Study Biological Arms,” New York Times, January 18, 1989, A7.
444. W. Seth Carus, " The Poor Man’s Atomic Bomb?” Biological Weapons in the Middle East, Policy Paper 23 (Washington, DC: Washington Institute for Near East Policy, 1991), 7-8
445. Milton Leitenberg, Biological Weapons Arms Control (College Park: Center for International and Security Studies at Maryland, 1996), 23.
446. CIA, Chemical and Biological Weapons: The Poor Man's Atomic Bomb, December 1988, FOIA.
447. United Nations Monitoring, Verification and Inspection Commission (UNMOVIC), Compendium of Iraq’s Proscribed Weapons Programmes in the Chemical, Biological and Missile Areas (New York: United Nations, 2007), 779-80 [hereafter Compendium].
448. Rod Barton, The Weapons Detective: The Inside Story of Australia's Top Weapons Inspector (Melbourne: Black Inc. Agenda, 2006), 53.
449. Sharon Begley, “The Germ Warfare Alert,” Newsweek, January 7, 1991, 25.
450. CIA, Beating Plowshares into Swords: Iraq's Defense Industrialization Program, NESA 90-10009.
451. UNMOVIC, Compendium, 780-82.
452. Tim Trevan, Saddam' Secrets: The Hunt for Iraq's Hidden Weapons (London: HarperCollins, 1999), 316-17
453. Graham S. Pearson, The UNSCOM Saga: Chemical and Biological Weapons Non-Proliferation (New York: St. Martin’s Press, 1999), 141
454. Gregory Koblentz, “Countering Dual-Use Facilities: Lessons from Iraq and Sudan,” Jane’s Intelligence Review 11, no. 3 (1999): 48-53.
455. UNMOVIC, Compendium, 833, 908, 925-26.
456. CIA, Intelligence Related to Possible Sources of Biological Agent Exposure.
457. CIA, Iraq: Foreign Dependency in Developing Weapons of Mass Destruction, January 1991, Gulf-link website.
458. Rod Barton, “The Application of the UNSCOM Experience to International Biological Arms Control,” Critical Reviews in Microbiology 24, no. 3 (1998): 222.
459. Lord Butler, Review of Intelligence on Weapons of Mass Destruction: Report of a Committee of Privy Counselors (London: The Stationery Office, 2004), 127-28
460. R. Jeffrey Smith, “Russians Admit Firms Met Iraqis,” Washington Post, February 18, 1998, A16.
461. Scott Ritter, Endgame: Solving the Iraq Problem Once and For AH (New York: Simon and Schuster, 1999), 220.
462. SSCI, Report on the Use by the Intelligence Community of Information Provided by the Iraqi National Congress (Washington, DC: GPO, 2006), 105-9, 121-22
463. John Goetz and Marcel Rosenbach, “German Intelligence Was ‘Dishonest, Unprofessional and Irresponsible’,” Der Spiegel, March 22, 2008, http://www.spiegel.de/international/world/0,1518,542888,00.html.
464. Tyler Drumheller, On Brink An Insider's Account of How the White House Compromised American Intelligence (New York: Carroll and Graf, 2006), 781-86.
465. Robert Jervis, “Reports, Politics, and Intelligence Failures: The Case of Iraq,” Journal of Strategic Studies 29, no. 1 (2006): 20-27.
466. Jean Krasno and James Sutterlin, The United Nations and Iraq: Defanging the Viper (Westport, CT: Praeger, 2003), 92.
467. Scott Ritter, Iraq Confidential: The Untold Story of the Intelligence Conspiracy to Undermine the UN and Overthrow Saddam Hussein (New York: Nation Books, 2005), 213-15, 248
468. Bob Drogin and Greg Miller, “Iraqi Defector’s Tales Bolstered U.S. Case for War,” Los Angeles Times, March 28, 2004.
469. James Risen, “CIA Held Back Iraqi Arms Data, U.S. Officials Say,” New York Times, July 6, 2004, A1
470. Douglas Jehl, “U.S., Certain That Iraq Had Illicit Arms, Reportedly Ignored Contrary Reports,” New York Times, March 6, 2004, A6
471. David Rose, “Iraq’s Arsenal of Terror,” Vanity Fair, May 2002, 120-31.
472. Douglas Jehl and David E. Sanger, “Powell’s Case, a Year Later: Gaps in Picture of Iraq Arms,” New York Times, February 1, 2004, A1.
473. Stuart A. Cohen, Iraq’s WMD Programs: Culling Hard Soft Myths, November 28, 2003, http://www.dni.gov/nic/articles_iraq_wmd.htm.
474. NIC, Iraq’s Continuing Program for Weapons of Mass Destruction, 7
475. James Risen, State of War: The Secret History of the CIA and the Bush Administration (New York: Free Press, 2006), 90-91, 106.
476. Douglas Jehl, “U.S., Certain That Iraq Had Illicit Arms, Reportedly Ignored Contrary Reports,” New York Times, March 6, 2004, A6.
477. James Risen, “CIA Held Back Iraqi Arms Data, U.S. Officials Say,” New York Times, July 6, 2004, A1.
478. Erich Follath, John Goetz, Marcel Rosenbach, and Holger Stark, “How German Intelligence Helped Justify the U.S. Invasion of Iraq,” Der Spiegel, March 22, 2008.
479. John Goetz and Bob Drogin, “‘Curveball’ Speaks, and a Reputation as a Disinformation Agent Remains Intact,” Los Angeles Times, June 18, 2008.
480. Bradley Graham, “Air Force Analysts Feel Vindicated on Iraqi Drones,” Washington Post, September 26, 2003, A23
481. Joby Warrick, “Lacking Biolabs, Trailers Carried the Case for War,” Washington Post, April 12, 2006, A1.
482. Paul R. Pillar, “Intelligence, Policy, and the War in Iraq,” Foreign Affairs 85, no. 2 (2006): 15-27.
483. DCI, The Technology Acquisition Efforts of the Soviet Intelligence Services, Interagency Intelligence Memorandum, June 1982, FOIA
484. Albert J. Mauroni, Chemical-Biological Defense: U.S. Military Policies and Decisions in the Gulf War (Westport, CT: Praeger, 1998), 136.
485. Christopher J. Davis, “Nuclear Blindness: An Overview of the Biological Weapons Programs of the Former Soviet Union and Iraq,” Emerging Infectious Diseases 5, no. 4 (1999): 509.
486. David C. Kelly, “The Trilateral Agreement: Lessons for Biological Weapons Verification,” in Verification Yearbook, 2002, ed. Trevor Findlay and Oliver Meier (London: VERTIC, 2002), 104
487. Tim Trevan, “Exploiting Intelligence in International Organizations,” in Biological Warfare: Modern Offense and Defense, ed. Raymond Zilinskas (Boulder, CO: Lynne Reinner, 2000), 207-24.
488. Barbara Hatch Rosenberg and Gordon Burck, “Verification of Compliance with the Biological Weapons Convention,” in Preventing a Biological Arms Race, ed. Susan Wright (Cambridge: MIT Press, 1990), 305 (italics in original).
489. Robert Jervis, Perception and Misperception in International Politics (Princeton: Princeton University Press, 1976), 64-66.
490. John R. Bolton, Undersecretary of State for Arms Control and International Security, “The International Aspects of Terrorism and Weapons of Mass Destruction,” Second Global Conference on Nuclear, BioIChem Terrorism. Hudson Institute, Washington, DC, November 1, 2002. http://www.state.govA/us/rm/14848.htm.
491. Steven R. Weisman, “In Stricter Study, U.S. Scales Back Claim on Cuba Arms,” New York Times, September 18, 2004, A7.
492. Jonathan B. Tucker, “Biological Threat Assessment: Is the Cure Worse Than the Disease?” Arms Control Today, October 2004, 13-19.
493. Kofi Annan, Uniting against Terrorism, Report of the Secretary-General, United Nations General Assembly A/60/825, April 27, 2006, 11, http://www.un.org/unitingagainstterrorism.
494. Bob Graham and Jim Talent, World at Risk Report of the Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism (New York: Vintage Books, 2008), xv.
495. Richard Falkenrath, Robert Newman, and Bradley Thayer, America's Achilles' Heel: Nuclear, Biological, and Chemical Terrorism and Covert Attack (Cambridge: MIT Press, 1998).
496. Jessica Stern, The Ultimate Terrorists (Cambridge: Harvard University Press, 1999).
497. Bonathan B. Tucker and Kathleen M. Vogel, “Preventing the Proliferation of Chemical and Biological Weapons Materials and Know-How,” Nonproliferation Review 7, no. 1 (2000): 88-96.
498. General Accounting Office, Need for Comprehensive Threat and Risk Assessments of Chemical and Biological Attacks, GAO-NSIAD-99-163 (Washington, DC: GAO, September 1999).
499. Milton Leitenberg, The Problem of Biological Weapons (Stockholm: Swedish National Defence College, 2004), 25-27.
500. W. Seth Carus, Bioterrorism and Biocrimes: The Illicit Use of Biological Agents since 1900 (Washington, DC: National Defense University, February 2001), 8.
501. George Christopher, et al., “Biological Warfare: A Historical Perspective,”Journal oftheAmerican Medical Association 278, no. 5 (1997): 412.
502. Spurgeon Neel, Medical Support of the U.S. Army in Vietnam, 1965-1970 (Washington, DC: Department of the Army, 1991), 54.
503. W. Seth Carus, “The Rajneeshees (1984),” in Toxic Terror: Assessing Terrorist Use of Chemical and Biological Weapons, ed. Jonathan B. Tucker (Cambridge: MIT Press, 2000), 115-37
504. Thomas J. Torok, et al., “A Large Community Outbreak of Salmonellosis Caused by Intentional Contamination of Restaurant Salad Bars,” in Biological Weapons: Limiting the Threat, ed. Joshua Lederberg (Cambridge: MIT Press, 1999), 167-84.
505. Susanne Lundberg, Lena Melin, Calle Nilsson, and Pontus von Schoenberg, Ricin: Threat, Effects and Protection (Umea: Swedish Defence Research Agency, June 2004)
506. Dana Shea and Frank Got-tron, Ricin: Technical Background and Potential Role in Terrorism (Washington, DC: Congressional Research Service, February 4, 2004).
507. Judith Miller, “Poison Found at Post Office,” New YorK Times, October 23, 2003, A14
508. David Johnston and Carl Hulse, “Finding of Deadly Poison in Office Disrupts the Senate,” New York Times, February 3, 2004, A1
509. Dan Eggen, “Letter with Ricin Vial Sent to White House,” Washington Post, February 4, 2004, A7.
510. Dorothy A. Canter, “Remediating Anthrax-Contaminated Sites: Learning from the Past to Protect the Future,” Chemical Health and Safety, July/August 2005, 16.
511. Leonard A. Cole, “WMD and Lessons from the Anthrax Attacks,” in The McGraw-Hill Homeland Security Handbook, ed. David G. Kamien (New York: McGraw-Hill, 2006), 170.
512. Daniel B. Jernigan, et al., “Investigation of Bioterrorism-Related Anthrax, United States, 2001: Epidemiologic Findings,” Emerging Infectious Diseases 8, no. 10 (2002): 1019-28.
513. Thomas F. Dellafera, “Affidavit in Support of Search Warrant,” Document 07-524-M-01, October 31, 2007, 4, http://www.usdoj.gov/amerithrax.
514. Lois Ember, “Anthrax Sleuthing,” Chemical and Engineering News 84, no. 49 (2006): 47-54.
515. Douglas J. Beecher, “Forensic Application of Microbiological Culture Analysis to Identify Mail Intentionally Contaminated with Bacillus anthracis Spores,” Applied and Environmental Microbiology 72, no. 8 (2006): 5309
516. Matthew Meselson and Ken Alibek, “Anthrax under the Microscope,” Washington Post, November 5, 2002, A24.
517. Vincent P. Hsu, et al., “Opening a Bacillusanthracis-Containing Envelope, Capitol Hill, Washington, DC: The Public Health Response,” Emerging Infectious Diseases 8, no. 10 (2002): 1039-43.
518. Christopher P. Weiss, et al., “Secondary Aerosolization of Viable Bacillus Anthracis Spores in a Contaminated U.S. Senate Office,” Journal of the American Medical Association 288, no. 22 (2002): 2853-58.
519. Rick Weiss and Ellen Nakashima, “More Mail Believed to Be Tainted,” Washington Post, December 4, 2001.
520. Department of Justice (DOJ), Transcript of Amerithrax Investigation Press Conference (Washington, DC: DOJ, August 6, 2008), http://www.usdoj.gov/opa/pr/2008/August/08-opa-697.html.
521. Carrie Johnson, “U.S. Settles with Scientist Named in Anthrax Cases,” Washington Post, June 28, 2008, A1.
522. Carrie Johnson and Joby Warrick, “Prosecutors Clear Hatfill in Anthrax Case,” Washington Post, August 9, 2008, A3.
523. Marilyn W. Thompson, Carrie Johnson, and Rob Stein, “FBI to Show How Genetics Led to Anthrax Researcher,” Washington Post, August 6, 2008, A3.
524. Scott Shane and Nicholas Wade, “Pressure Grows for FBI’s Anthrax Evidence,” New York Times, August 5, 2008
525. Brian Williams, “Five Year Anniversary of First US Anthrax Terrorist Death,” NBC Nightly News, October 5, 2006.
526. DOJ, Transcript of Amerithrax Investigation Press Conference.
527. United States Army Medical Research Command, AR 15-6 Investigation into Anthrax Contamination at USAMRIID, May 16, 2002.
528. Caree Vander Linden, “USAMRIID Employees Earn Top Civilian Award,” Fort Detrick Standard, March 19, 2003.
529. Jim Garamore, “DOD Slows Anthrax Vaccination Program Again,” American Forces Press Service, June 11, 2001.
530. Nicholas Wade, “U.S. Moves toward Making Anthrax Vaccine Available,” New York Times, October 27, 2001, B7.
531. B. Kournikakis, et al., Risk Assessment of Anthrax Threat Letters, DRES TR-2001-048 (Suffield, Canada: Defense Research Establishment Suffield, September 2001).
532. William C. Patrick III “Potential Incident Scenarios,” in U.S. Public Health Service, Proceedings of the Seminar on Responding to the Consequences of Chemical and Biological Terrorism, July 11-14, 1995 (Washington, DC: GPO, 1996), chapter 1.
533. David Altimari, “Anthrax Vaccine Safety Complaints Part of Ivins Case,” Hartford Courant, August 6, 2008.
534. Eileen Choffnes, “Bioweapons: New Labs, More Terror?” Bulletin of the Atomic Scientists 58, no. 5 (2002): 28-32.
535. Nick Shwellenbach, “Biodefense: A Plague of Researchers,” Bulletin of the Atomic Scientists 61, no. 3 (2005): 14-16.
536. Gary Matsumoto, “Anthrax Powder: State of the Art?” Science 302 (November 28, 2003): 1492-96.
537. FBI, FBI Roundtable Discussion Regarding the Anthrax Investigation.
538. Carrie Johnson, Joby Warrick, and Marilyn W. Thompson, “Anthrax Dryer a Key to Probe,” Washington Post, August 5, 2008, A1.
539. Kathleen Vogel, “Bioweapons Proliferation: Where Science Studies and Public Policy Collide,” Social Studies of Science 36, no. 5 (2006): 659-90.
540. Masaki Sugishima, “Biocrimes in Japan,” in A Comprehensive Study on Bioterrorism, ed. Masaki Sugishima (Gifu, Japan: Asahi University, 2003), 98-101.
541. David E. Kaplan, “Aum Shinrikyo (1995),” in Toxic Terror, ed. Tucker, 220.
542. William Rosenau, “Aum Shinrikyo’s Biological Weapons Program: Why Did it Fail?” Studies in Conflict and Terrorism 24 (2001): 289-301
543. Amy E. Smithson and Leslie-Anne Levy, Ataxia: The Chemical and Biological Terrorism Threat and the U.S. Response (Washington, DC: Henry L. Stimson Center, 2000), 71-111
544. Milton Leitenberg, “Aum Shinrikyo’s Effort to Produce Biological Weapons: A Case Study of the Serial Propagation of Misinformation,” Terrorism and Political Violence 11, no. 4 (1999): 149-58.
545. Robert Jay Lifton, Destroying the World to Save It: Aum Shinrikyo, Apocalyptic Violence and the New Global Terrorism (New York: Metropolitan Books, 1999), 157-59
546. Anthony T. Tu, Chemical Terrorism: Horrors in Tokyo Subway and Matsumoto City (Fort Collins, CO: Alaken, 2002), 190.
547. Raymond Zilinskas, “Possible Terrorist Use of Modern Biotechnology Techniques” (paper presented at Conference on Biosecurity, Istituto Diplomatico, Rome, Italy, September 18-19, 2000)
548. Christopher F. Chyba and Alexander L. Greninger, “Biotechnology and Bioterrorism: An Unprecedented World,” Survival 46, no. 2 (2004): 143-62.
549. House Homeland Security Committee, Bioscience and the Intelligence Community, 109th Cong., 1st and 2nd sess., November 3, 2005, and May 4, 2006, 47.
550. President George W. Bush, “President Speaks on War Effort to Citadel Cadets,” December 11, 2001, http://www.whitehouse.gov/news/releases/2001/12/20011211-6.html.
551. Steven Simon and Daniel Benjamin, “America and the New Terrorism,” Survival 42, no. 1 (2000): 59-75.
552. James T. Quinlivan, “Coup Proofing: Its Practice and Consequences in the Middle East,” International Security 24, no. 2 (1999): 131-65.
553. Daniel Byman, Deadly Connections: States That Sponsor Terrorism (New York: Cambridge University Press, 2005), 1-78
554. Bruce Hoffman, Inside Terrorism (New York: Columbia University Press, 2006), 258-67.
555. Brad Roberts, “Rethinking How Wars Must End: NBC War Termination Issues in the Post-Cold War Era,” in The Coming Crisis: Nuclear Proliferation, U.S. Interests, and World Order, ed. Victor A. Utgoff (Cambridge: MIT Press, 2000), 245-77.
556. Scott Sagan, “The Commitment Trap: Why the United States Should Not Use Nuclear Threats to Deter Biological and Chemical Weapon Attacks,” International Security 24, no. 4 (2000): 85-115.
557. Jasen J. Castillo, “Nuclear Terrorism: Why Deterrence Still Matters,” Current History 102, no. 668 (2003): 426-31.
558. Jeffrey Richelson, America’s Space Sentinels: DSP Satellites and National Security (Lawrence: University of Kansas Press, 1999).
559. Bruce Budowle, et al., “Microbial Forensics,” in Microbial Forensics, ed. Roger G. Breeze, Bruce Budowle, and Steven E. Schutzer (Boston: Elsevier Press, 2005), 9.
560. Bruce Budowle, et al., “Building Microbial Forensics as a Response to Bioterrorism,” Science 301 (September 26, 2003): 1852.
561. American Academy of Microbiology, Microbial Forensics: A Scientific Assessment (Washington, DC: American Academy of Microbiology, 2003)
562. Charlene M. Schaldach, “Non-DNA Methods for Biological Signatures,” in Microbial Forensics, ed. Breeze, Budowle, and Schutzer, 251-94.
563. Paul Keim, et al., “Molecular Evolution and Diversity in Bacillus anthracis as Detected by Amplified Fragment Length Polymorphism Markers,” Journal of Bacteriology 179, no. 3 (1997): 818-24.
564. L. Lindler, et al., “Genetic Fingerprinting of Biodefense Pathogens for Epidemiology and Forensic Investigation,” in Biological Weapons Defense: Infectious Diseases and Counterbioterrorism, ed. Luther E. Lindler, Frank J. Lebeda, and George W. Korch (Totowa, NJ: Humana Press, 2005), 457-59.
565. Martin Enserink, “Full-Genome Sequencing Paved the Way from Spores to a Suspect,” Science 321 (August 15, 2008): 898-99
566. Gregory F. Giles, “The Islamic Republic of Iran and Nuclear, Biological, and Chemical Weapons,” in Planning the Unthinkable: How New Powers Will Use Nuclear, Biological and Chemical Weapons, ed. Peter Lavoy, Scott Sagan, and James Wirtz (Ithaca: Cornell University Press, 2000), 79-80
567. Douglas Jehl, “U.S. Intelligence Review Is Softening Some Judgments about Illicit Arms Abroad,” New York Times, November 18, 2003, A6
568. Department of Commerce, India and Pakistan Sanctions and Other Measures,” Federal Register 63, no. 23 (1998): 64337-41.
569. Alan Cullison and Andrew Higgins, “Files Found: A Computer in Kabul Yields a Chilling Array of al Qaeda Memos,” Wall Street Journal, December 31, 2001
570. Alan Cullison, “Inside Al-Qaeda’s Hard Drive,” Atlantic Monthly 294, no. 4 (2004): 55-70.
571. Abu Walid al-Misri, The History of the Arab Afghans from the Time of Their Arrival in Afghanistan until Their Departure with the Taliban, serialized in Asharq Al-Awsat, December 8-14, 2004.
572. George Tenet, At the Center of the Storm: My Years at the CIA, with Bill Harlow (New York: HarperCollins, 2007), 278.
573. Eric Lipton, “Qaeda Letters Are Said to Show Pre-9/11 Anthrax Plans,” New York Times, May 21, 2005, A9
574. Joby Warrick, “Suspect and A Setback in Al-Qaeda Anthrax Case,” Washington Post, October 31, 2006, A1.
575. White House, “President Discusses Creation of Military Commissions to Try Suspected Terrorists,” September 6, 2006, http://www.whitehouse.gov/news/releases/2006/09/print/20060906-3.html.
576. Maria Ressa, “Al Qaeda Operative Sought Anthrax,” CNN.com, October 10, 2003.
577. Judith Miller, “Lab Suggests Qaeda Planned to Build Arms, Officials Say,” New York Times, September 14, 2002, A7.
578. Barton Gellman, “Al Qaeda near Biological, Chemical Arms Production,” Washington Post, March 23, 2003, A1.
579. James Petro and David A. Relman, “Understanding Threats to Scientific Openness,” Science 302 (December 12, 2003): 1898.
580. Andrew McGregor, “Ricin Fever: Abu Musab al-Zarqawi in the Pankisi Gorge,” Terrorism Monitor 2, no. 24 (2004): 10-12.
581. Steve Coll and Susan B. Glasser, “Terrorists Turn to the Web as Base of Operations,” Washington Post, August 7, 2005, A1.
582. Sammy Salama and Lydia Hansell, “Does Intent Equal Capability? Al-Qaeda and Weapons of Mass Destruction,” Nonproliferation Review 12, no. 3 (2005): 615-53.
583. Anne Stenersen, “Chem-Bio Cyber-Class,” Jane’s Intelligence Review, September 2007, 8-13
584. Adam Dolnik and Rohan Gunaratna, “Jemaah Islamiyah and the Threat of Chemical and Biological Terrorism,” in Weapons of Mass Destruction and Terrorism, ed. Russell D. Howard and James J. F. Forest (McGraw-Hill, 2008), 280-94.
585. Marc Sageman, Leaderless Jihad: Terror Network in the Twenty-first Century (Philadelphia: University of Pennsylvania Press, 2008).
586. Brynjar Lia, Architect of Global Jihad: The Life of Al-Qaida Strategist Abu Mus'ab al-Suri (New York: Columbia University Press, 2008), 1-28, 299-313.
587. Jonathan B. Tucker and Jason Pate, “The Minnesota Patriots Council (1991),” in Toxic Terror, ed. Tucker, 159-83.
588. CIA, Terrorist CBRN: Materials and Effects (Langley, VA: CIA, May 2003).
589. Institute of Medicine and National Research Council, Globalization, Biosecurity, and the Future of the Life Sciences (Washington, DC: National Academies Press, 2006).
590. Robert Carlson, “The Pace and Proliferation of Biological Technologies,” Biosecurity and Bioterrorism 1, no. 3 (2003): 1-12.
591. Matthew Meselson, “Averting the Hostile Exploitation of Biotechnology,” CBW Conventions Bulletin 48 (June 2000): 16-19.
592. Alan Pearson, Federal Funding for Biological Weapons Prevention and Defense, Fiscal Years 2001 to 2009 (Washington, DC: Center for Arms Control and Non-Proliferation, 2008).
593. Clare Fraser, “A Genomics-Based Approach to Biodefense Preparedness,” Nature Reviews Genetics 5 (2004): 23-33.
594. National Research Council, Seeking Security: Pathogens, Open Access, and Genome Databases (Washington, DC: National Academies Press, 2004), 31-33.
595. Renae Merle, “Bioterror Antidote: Unfulfilled Prescription,” Washington Post, January 16, 2007, D1.
596. “U.S. Biodefense-Shocking and Awful,” Nature Biotechnology 25, no. 6 (2007): 603.
597. Kendall Hoyt, “The Role of Military-Industrial Relations in the History of Vaccine Innovation” (PhD diss., Massachusetts Institute of Technology, 2002), chap. 5.
598. Office of the Secretary of Defense, Proliferation: Threat and Response (Washington, DC: Department of Defense, 2001), 92-94, 199-20.
599. James W. Buehler, et al., “Syndromic Surveillance and Bioterrorism-Related Epidemics,” Emerging Infectious Diseases 9, no. 10 (2003): 1197-1204.
600. Michael A. Stoto, Matthias Schonlau, and Louis T. Mariano, “Syndromic Surveillance: Is It Worth the Effort?” Chance 17, no. 1 (2004): 19-24.
601. Michael G. Baker and David P. Fidler, “Global Public Health Surveillance under New International Health Regulations,” Emerging Infectious Diseases 12, no. 7 (2006): 1058-65.
602. Stefan Elbe, Strategic Implications of HIV/AIDS, Adelphi Paper No. 357 (Oxford: Oxford University Press, 2003).
603. Christian Enemark, Disease and Security: Natural Plagues and Biological Weapons in East Asia (New York: Routledge, 2007).
604. Jonathan B. Tucker, “Preventing the Misuse of Pathogens: The Need for Global Biosecurity Standards,” Arms Control Today (June 2003): 3-10.
605. United Nations Security Council, Resolution 1540, S/RES/1540 (2004), April 28, 2004.
606. Kendall Hoyt and Stephen G. Brooks, “A Double-Edged Sword: Globalization and Biosecurity,” International Security 28, no. 3 (2003/4): 123-48.
607. National Research Council, Biotechnology Research in an Age of Terrorism: Confronting the Dual Use Dilemma (Washington, DC: National Academies Press, 2004).
608. NSABB, Proposed Framework for the Oversight of Dual Use Life Sciences Research: Strategies for Minimizing the Potential Misuse of Research Information (Washington, DC: NSABB, June 2007).
609. NSABB, Proposed Framework for the Oversight of Dual Use Life Sciences Research, 17.
610. Margaret S. Race and Edward Hammond, “An Evaluation of the Role and Effectiveness of Institutional Biosafety Committees in Providing Oversight and Security of Biocontainment Laboratories,” Biosecurity and Bioterrorism 6, no. 1 (2008): 19-35.
611. Brian Rappert, Biotechnology, Security and the Searchfor Limits: An Inquiry into Research and Methods (New York: Palgrave Macmillan, 2007).
612. Malcom Dando, “Raising Life Scientists’ Awareness,” Bulletin of the Atomic Scientists (June 9, 2008), http://www.thebulletin.org/node/3122.
613. Margaret A. Somerville and Ronald M. Atlas, “Ethics: A Weapon to Counter Bioterrorism,” Science 307 (March 25, 2005): 1881-82.
614. 3LSI Research: An Essential Element of Biodefense,” Biosecurity and Bioterrorism 3, no. 2 (2005): 128-37.
615. Elisa D. Harris, Nancy Gallagher, and Stacy M. Okutani, Controlling Dangerous Pathogens: A Prototype Protective Oversight System (College Park: Center for International and Security Studies at Maryland, March 2007).
616. Jonathan B. Tucker and Stacy M. Okutani, Global Governance of "Contentious” Science: The Case of the World Health Organization s Oversight of Smallpox Virus Research, paper no. 18, (Stockholm: Weapons of Mass Destruction Commission, n.d.).
617. Milton Leitenberg, James Leonard, and Richard Spertzel, “Biodefense Crossing the Line,” Politics and the Life Sciences 22, no. 4 (2004): 1-2.
618. Jonathan B. Tucker, “Biological Threat Assessment: Is the Cure Worse Than the Disease?” Arms Control Today (October 2004): 13-19.
619. James B. Petro and W. Seth Carus, “Biological Threat Characterization Research: A Critical Component of National Biodefense,” Biosecurity and Bioterrorism 3, no. 4 (2005): 295-308.
620. Steven R. Weisman, “In Stricter Study, U.S. Scales Back Claim on Cuba Arms,” New York Times, September 18, 2004, A5.
621. Department of State, Adherence to and Compliance with Arms Control, Nonproliferation and Disarmament Agreements and Commitments (Washington, DC: Department of State, 2005), 19-20, 24-25
622. Commission on the Intelligence Capabilities of the United States Regarding Weapons of Mass Destruction, Report to the President (Washington, DC: GPO, 2005), 252-58.
623. Jeffrey T. Richelson, “MASINT: The New Kid in Town,” International Journal of Intelligence and Counterintelligence 14 (2001): 149-92.
624. Amy Sands, “Integrating Open Sources into Transnational Threat Assessments,” in Transforming U.S. Intelligence, ed. Jennifer E. Sims and Burton Gerber (Washington, DC: Georgetown University Press, 2005), 63-78.
625. Judith Miller and William Broad, “Iranians, Bioweapons in Mind, Lure Needy Ex-Soviet Scientists,” New York Times, December 8, 1998, A1
626. R. Jeffrey Smith, “Russians Admit Firms Met Iraqis; Plants That Could Make Germ Weapons at Issue,” Washington Post, February 18, 1998, A16.
627. Kathleen M. Vogel, “Pathogen Proliferation: Threats from the Former Soviet Bioweapons Complex,” Politics and the Life Sciences 19, no. 1 (2000): 3-16.
628. Amy Smithson, Toxic Archipelago: Preventing Proliferation from the Former Soviet Chemical and Biological Weapons Complexes (Washington, DC: Henry L. Stimson Center, 1999)
629. Judith Miller, Stephen Engelberg, and William Broad, Germs: Biological Weapons and America's Secret War (New York: Simon and Schuster, 2001), 228-29.
630. Jonathan Tucker, Scourge: The Once and Future Threat of Smallpox (New York: Atlantic Monthly Press, 2001), 226-29.
631. Matthew Meselson and Julian Robinson, A Draft Convention to Prohibit Biological and Chemical Weapons under International Criminal Law (Cambridge: Harvard Sussex Program on CBW Armament and Arms Limitation, March 2003)
632. Barry Kellman, “Draft Model Convention on the Prohibition and Prevention of Biological Terrorism,” Terrorism and Political Violence 14, no. 4 (2002): 163-208.
633. Alan Pearson, “Incapacitating Biochemical Weapons: Science, Technology and Policy for the 21st Century,” Nonproliferation Review 13, no. 2 (2006): 151-81.
634. Mark Wheelis, “Will the ‘New Biology’ Lead to New Weapons?” Arms Control Today (July/August 2004): 6-13.
635. Mark Wheelis and Malcolm Dando, “Neurobiology: A Case Study of the Imminent Militarization of Biology,” International Review of the Red Cross 87, no. 859 (2005): 553-68.